var title_f1_56_1920="BAL fluid in non smokers";
var content_f1_56_1920=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50382%7EPULM%2F71367%7EPULM%2F66165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=16\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50382%7EPULM%2F71367%7EPULM%2F66165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=16\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy never smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn; SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        63.4 &plusmn; 1.1",
"       </td>",
"       <td>",
"        40.8",
"       </td>",
"       <td>",
"        80.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        18.1 &plusmn; 1.9",
"       </td>",
"       <td>",
"        5.2",
"       </td>",
"       <td>",
"        33.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        12.9 &plusmn; 2.0",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"       <td>",
"        35.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        85.2 &plusmn; 1.6",
"       </td>",
"       <td>",
"        54.6",
"       </td>",
"       <td>",
"        97.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        9.9 &plusmn; 0.8",
"       </td>",
"       <td>",
"        2.7",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.81 &plusmn; 1.1",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"       <td>",
"        34.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.49 &plusmn; 0.25",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        4.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.7",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.2 &plusmn; 1.1",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.19 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.02 &plusmn; 0.007",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        70.27 &plusmn; 3.56",
"       </td>",
"       <td>",
"        25.6",
"       </td>",
"       <td>",
"        94.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        44.4 &plusmn; 3.71",
"       </td>",
"       <td>",
"        7.6",
"       </td>",
"       <td>",
"        83.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        20.73 &plusmn; 2.17",
"       </td>",
"       <td>",
"        6.6",
"       </td>",
"       <td>",
"        49.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        2.61 &plusmn; 0.29",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        6.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        3.23 &plusmn; 0.85",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        17.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        5.92 &plusmn; 0.48",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        14.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        6.22 &plusmn; 0.60",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"       <td>",
"        15.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.20 &plusmn; 0.019",
"       </td>",
"       <td>",
"        0.03",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        34.23 &plusmn; 1.67",
"       </td>",
"       <td>",
"        15.7",
"       </td>",
"       <td>",
"        59.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        78.24 &plusmn; 4.04",
"       </td>",
"       <td>",
"        39.5",
"       </td>",
"       <td>",
"        140.7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 77.",
"        <br>",
"         &loz; n = 30.",
"         <br>",
"          &sect; n = 76.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy former smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn;&nbsp;SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        62.3 &plusmn; 1.4",
"       </td>",
"       <td>",
"        42.6",
"       </td>",
"       <td>",
"        80.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        20.01 &plusmn; 1.5",
"       </td>",
"       <td>",
"        8.7",
"       </td>",
"       <td>",
"        44.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        13.9 &plusmn; 1.1",
"       </td>",
"       <td>",
"        5.2",
"       </td>",
"       <td>",
"        31.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        86.5 &plusmn; 1.4",
"       </td>",
"       <td>",
"        66.6",
"       </td>",
"       <td>",
"        97.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.9 &plusmn; 0.9",
"       </td>",
"       <td>",
"        4.0",
"       </td>",
"       <td>",
"        29.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        11.5 &plusmn; 1.2",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        29.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.69 &plusmn; 0.31",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        2.1 &plusmn; 0.5",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        8.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.27 &plusmn; 0.049",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.2 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.08 &plusmn; 0.035",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        74.23 &plusmn; 4.31",
"       </td>",
"       <td>",
"        15.8",
"       </td>",
"       <td>",
"        96.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        46.88 &plusmn; 3.69",
"       </td>",
"       <td>",
"        11.2",
"       </td>",
"       <td>",
"        77.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        20.65 &plusmn; 2.14",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        44.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        2.78 &plusmn; 0.32",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        6.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        3.46 &plusmn; 1.00",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        17.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        9.14 &plusmn; 0.82",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"       <td>",
"        17.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        7.63 &plusmn; 0.80",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"       <td>",
"        22.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.33 &plusmn; 0.06",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        46.39 &plusmn; 3.82",
"       </td>",
"       <td>",
"        13.6",
"       </td>",
"       <td>",
"        84.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        97.69 &plusmn; 5.78",
"       </td>",
"       <td>",
"        43.4",
"       </td>",
"       <td>",
"        171.1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 50.",
"        <br>",
"         &loz; n = 26.",
"         <br>",
"          &sect; = 46.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn; SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        59.2 &plusmn; 1.4",
"       </td>",
"       <td>",
"        35.9",
"       </td>",
"       <td>",
"        74.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        59.9 &plusmn; 7.3",
"       </td>",
"       <td>",
"        10.5",
"       </td>",
"       <td>",
"        176.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/ml, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        41.8 &plusmn; 4.5",
"       </td>",
"       <td>",
"        8.1",
"       </td>",
"       <td>",
"        117.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        92.5 &plusmn; 1.0",
"       </td>",
"       <td>",
"        79.5",
"       </td>",
"       <td>",
"        99.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        39.0 &plusmn; 4.3",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"       <td>",
"        108.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        5.2 &plusmn; 0.9",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        18.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.74 &plusmn; 0.28",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        7.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.2",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.82 &plusmn; 0.18",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.56 &plusmn; 0.13&nbsp;",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.28 &plusmn; 0.09",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        69.2 &plusmn; 4.32",
"       </td>",
"       <td>",
"        15.0",
"       </td>",
"       <td>",
"        95.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        32.21 &plusmn; 2.71",
"       </td>",
"       <td>",
"        9.0",
"       </td>",
"       <td>",
"        65",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        29.2 &plusmn; 3.0",
"       </td>",
"       <td>",
"        5.0",
"       </td>",
"       <td>",
"        58",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        1.64 &plusmn; 0.29",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        6.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        6.54 &plusmn; 1.54",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        28.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        10.22 &plusmn; 0.90",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        22.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        5.94 &plusmn; 0.53",
"       </td>",
"       <td>",
"        1.06",
"       </td>",
"       <td>",
"        15.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.227 &plusmn; 0.05",
"       </td>",
"       <td>",
"        0.01",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        42.92 &plusmn; 2.73",
"       </td>",
"       <td>",
"        14.0",
"       </td>",
"       <td>",
"        91.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        95.39 &plusmn; 5.24",
"       </td>",
"       <td>",
"        37.8",
"       </td>",
"       <td>",
"        182.7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 64.",
"        <br>",
"         &loz; n = 29.",
"         <br>",
"          &sect; n = 62.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1920=[""].join("\n");
var outline_f1_56_1920=null;
var title_f1_56_1921="Septal hematoma";
var content_f1_56_1921=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral septal hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Handler SD, Myer CM. Atlas of ear, nose and throat disorders in children. Ontario, Canada: BC Decker; 1998:52. Copyright &copy; 1998 PMPH-USA, Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1921=[""].join("\n");
var outline_f1_56_1921=null;
var title_f1_56_1922="Chapter 10C: Intracellular pH";
var content_f1_56_1922=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 10C: Intracellular pH",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1922/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/56/1922/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intracellular pH can be measured with a variety of techniques, including the distribution of a weak acid or base, nuclear magnetic resonance spectroscopy, the insertion of a H+-sensitive microelectrode, and the use of fluorescent dyes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In general, the cytosolic pH has been noted to be lower than that in the extracellular fluid, although it varies from organ to organ. For example, at a normal extracellular pH of 7.40, the mean pH in skeletal or smooth muscle is about 7.06 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/1\">",
"     1",
"    </a>",
"    ], whereas that in the early proximal convoluted tubule is approximately 7.13 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is, however, one problem in interpretation of the intracellular pH. In contrast to the value in the extracellular fluid, the pH within the cell is not uniform because of the presence of multiple compartments, including the cytosol, mitochondria, endoplasmic reticulum, and nucleus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/4\">",
"     4",
"    </a>",
"    ]. As depicted in the following figure (",
"    <a class=\"graphic graphic_figure graphicRef80037 \" href=\"UTD.htm?36/56/37773\">",
"     figure 1",
"    </a>",
"    ), a difference of approximately 0.5 pH units is obtained when the cell pH of skeletal muscle is measured with both a weak acid, which is preferentially bound to the alkaline regions in the cell, and a weak base, which is preferentially bound to the more acidic areas in the cell. At an extracellular pH of 7.40, for example, the respective values for the intracellular pH are 7.17 and 6.69, respectively.",
"   </p>",
"   <p>",
"    As a result of this heterogeneity, it is difficult to determine which pH reflects the value that regulates the specific cellular function that is being studied. In the proximal tubular cell, for example, extracellular acidemia stimulates NH4+ production and secretion, primarily via the breakdown of glutamine&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=see_link&amp;anchor=H10#H10\">",
"     \"Chapter 11A: Renal hydrogen excretion\", section on 'Ammonium excretion'",
"    </a>",
"    ). It is thought that the initiating signal for this metabolic change is in part the parallel fall that occurs in the intracellular pH [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/5\">",
"     5",
"    </a>",
"    ]. However, studies using both nuclear magnetic resonance and the distribution of a weak acid suggest that, although the cytosolic pH declines, the mitochondrial pH may remain relatively stable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. It may be that this increase in the transmitochondrial pH gradient, rather than the cytosolic pH alone, is the signal to alter the production of NH4+.",
"   </p>",
"   <p>",
"    Several factors contribute to the regulation of intracellular pH, including the rate of metabolic activity, tissue perfusion, and the extracellular pH. As illustrated in the following figure (",
"    <a class=\"graphic graphic_figure graphicRef80037 \" href=\"UTD.htm?36/56/37773\">",
"     figure 1",
"    </a>",
"    ), alterations in the pH of the extracellular fluid produce parallel, although lesser, changes within the cells [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/2\">",
"     2",
"    </a>",
"    ]. The more efficient maintenance of intracellular pH is in part related to the greater buffering capacity within the cells.",
"   </p>",
"   <p>",
"    This relationship between the pH in the two fluid compartments is extremely important in the clinical setting. The principal physiologic effect of changes in pH is on protein function. Since the cells are the functioning units in the body, it is the intracellular pH that is of primary importance, yet it is only the extracellular (plasma) pH that can be easily measured in patients. Fortunately, this still permits an accurate assessment of acid-base status, because of the direct relationship between these two parameters.",
"   </p>",
"   <p>",
"    The mechanism by which the cells sense alterations in extracellular pH is incompletely understood. Changes in the PCO2 are presumably sensed directly, since CO2 is lipid-soluble and can freely diffuse across the cell membranes. In comparison, the effect of variations in the plasma HCO3- concentration is somewhat indirect. In the proximal convoluted tubule, for example, HCO3- leaves the cell across the basolateral membrane via a Na+-3HCO3- carrier. This process is stimulated in metabolic acidosis, since the associated reduction in the extracellular HCO3- concentration creates a favorable gradient for HCO3- exit from the cell [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1922/abstract/5\">",
"     5",
"    </a>",
"    ]. The result is a fall in the intracellular pH, which, as will be described in the next chapter, appears to be an important mediator of the appropriate increase in urinary NH4+ excretion that tends to raise the extracellular pH toward normal.",
"   </p>",
"   <p>",
"    This text is continued separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=see_link\">",
"     \"Chapter 11A: Renal hydrogen excretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/1\">",
"      Wray S. Smooth muscle intracellular pH: measurement, regulation, and function. Am J Physiol 1988; 254:C213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/2\">",
"      Adler S. The simultaneous determination of muscle cell pH using a weak acid and weak base. J Clin Invest 1972; 51:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/3\">",
"      Pastoriza-Munoz E, Harrington RM, Graber ML. Axial heterogeneity of intracellular pH in rat proximal convoluted tubule. J Clin Invest 1987; 80:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/4\">",
"      Ganapathy V, Leibach FH. Protons and regulation of biological functions. Kidney Int Suppl 1991; 33:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/5\">",
"      Krapf R, Berry CA, Alpern RJ, Rector FC Jr. Regulation of cell pH by ambient bicarbonate, carbon dioxide tension, and pH in the rabbit proximal convoluted tubule. J Clin Invest 1988; 81:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/6\">",
"      Adler S, Shoubridge E, Radda GK. Estimation of cellular pH gradients with 31P-NMR in intact rabbit renal tubular cells. Am J Physiol 1984; 247:C188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1922/abstract/7\">",
"      Simpson DP, Hager SR. Bicarbonate-carbon dioxide buffer system: a determinant of the mitochondrial pH gradient. Am J Physiol 1984; 247:F440.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7272 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-189.2.19.178-DF24B1B659-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1922=[""].join("\n");
var outline_f1_56_1922=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7272\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7272|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/56/37773\" title=\"figure 1\">",
"      Measurement of cell pH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12762?source=related_link\">",
"      Chapter 11A: Renal hydrogen excretion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1923="Patient information: Gallbladder removal (cholecystectomy) (The Basics)";
var content_f1_56_1923=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16271\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/37/27220\">",
"         Anatomy of the gallbladder",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29010\">",
"          Laparoscopic surgery (gallbladder removal)",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/29/8658\">",
"         Patient information: Gallstones (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/26/42401\">",
"         Patient information: Pancreatitis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?40/36/41537\">",
"         Patient information: Acute pancreatitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/45/26322\">",
"         Patient information: Chronic pancreatitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/9/30865\">",
"         Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/21/7507\">",
"         Patient information: Gallstones (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Gallbladder removal (cholecystectomy) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/gallbladder-removal-cholecystectomy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H7601103\">",
"      <span class=\"h1\">",
"       What is the gallbladder?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The gallbladder is a small, pear-shaped organ that is tucked under your liver (",
"      <a class=\"graphic graphic_figure graphicRef68129 \" href=\"UTD.htm?26/37/27220\">",
"       figure 1",
"      </a>",
"      ). It stores bile, a fluid that is made in the liver and helps the body break down fat. When you eat a meal that has fat in it, the gallbladder empties the bile into a tube called the &ldquo;bile duct.&rdquo; The bile duct carries the bile into the small intestine to help with digestion.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601120\">",
"      <span class=\"h1\">",
"       What is gallbladder removal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Gallbladder removal is surgery to remove the gallbladder. This surgery is also called &ldquo;cholecystectomy.&rdquo;",
"     </p>",
"     <p>",
"      There are 2 main ways to remove the gallbladder:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Using laparoscopic surgery",
"        </strong>",
"        &ndash; This means the surgeon uses a &ldquo;laparoscope,&rdquo; a long, thin tube that has a light and a tiny camera on the end to see inside the body. (The laparoscope is sometimes called a &ldquo;scope&rdquo; for short.) The camera on the scope sends pictures of the inside of the body to a TV screen. When doing this type of surgery, the surgeon makes a small incision&mdash;usually in the belly button&mdash;just big enough for the scope to fit through. Then the surgeon inflates the belly with carbon dioxide gas to lift up the skin and muscle and make everything inside easier to see. Next the surgeon makes 2 or more other incisions that narrow tools can fit through. These tools include clamps, scissors, and stitching devices, which the surgeon can control from outside the body. While looking at the picture on the screen, the surgeon uses those tools to do the operation (",
"        <a class=\"graphic graphic_figure graphicRef56022 \" href=\"UTD.htm?28/21/29010\">",
"         figure 2",
"        </a>",
"        ). Most gallbladder removals in the US are done using laparoscopic surgery, but sometimes open surgery is necessary because the gallbladder and bile duct are too infected or scarred to do laparoscopic surgery safely.",
"       </li>",
"       <li>",
"        <strong>",
"         Using open surgery &ndash;",
"        </strong>",
"        This means the surgeon makes an incision in your belly big enough to do the surgery directly.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601137\">",
"      <span class=\"h1\">",
"       Why would a person have his or her gallbladder removed?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common reason is to treat gallstones. Gallstones are small stones that form inside the gallbladder. These stones can block the ducts that bile flows through. The stones can cause inflammation, pain, and other symptoms.",
"     </p>",
"     <p>",
"      This article is about gallbladder removal to treat gallstones. People can also have gallbladder removal to treat cancer of the gallbladder. But if cancer is the reason for the surgery, it usually involves removing more than just the gallbladder.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601152\">",
"      <span class=\"h1\">",
"       What happens before gallbladder removal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Before the surgery:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Your doctor will order blood tests to check if your liver is working normally.",
"       </li>",
"       <li>",
"        Your doctor will order an imaging test called an ultrasound, which uses sound waves to create pictures of the inside of your body. This test will show if you have gallstones and if the bile duct is enlarged or blocked.",
"       </li>",
"       <li>",
"        If the bile duct is blocked by a stone, your doctor might order a procedure called &ldquo;ERCP.&rdquo; ERCP stands for &ldquo;endoscopic retrograde cholangiopancreatography.&rdquo; During this procedure, a doctor slides a tube called an &ldquo;endoscope&rdquo; down your throat. The endoscope has a tiny camera and a light on the end. The doctor advances the tube past your stomach and into your intestine to the spot where the bile duct empties into the intestine. Then the doctor injects a special dye that shows up on x-ray into the ducts that leads to the gallbladder, liver, and pancreas and takes an x-ray. That way he or she can see where the dye goes. In some cases, the doctor might also use the endoscope to remove some gallstones or widen the duct opening so that small stones can pass through.",
"       </li>",
"       <li>",
"        Your doctor will give you antibiotics by vein to reduce the risk of infection during and after surgery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601169\">",
"      <span class=\"h1\">",
"       What are the benefits of gallbladder removal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have the surgery to treat gallstones, the main benefit is that it will make your symptoms go away.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601186\">",
"      <span class=\"h1\">",
"       What are the risks of gallbladder removal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The risks of the surgery are low, but they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Damage to the ducts near the gallbladder and liver that carry bile",
"       </li>",
"       <li>",
"        Bile leaks",
"       </li>",
"       <li>",
"        Bleeding",
"       </li>",
"       <li>",
"        Damage to the bowels",
"       </li>",
"       <li>",
"        Infection",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601201\">",
"      <span class=\"h1\">",
"       What will my recovery be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Recovery is a little different depending on whether you have laparoscopic or open surgery.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        If you have laparoscopic surgery, you will probably be able to leave the hospital the same day you have surgery. But there is some chance you will need to stay overnight. Even though the cuts on the belly are small, the operation inside was big. Your doctor will want you to rest and avoid heavy lifting, sports, and swimming for at least a week.",
"       </li>",
"       <li>",
"        If you have open surgery, you will probably stay in the hospital 1 to 2 days. While there, do your best to start walking as soon as possible. Also, do the breathing exercises that your nurse recommends. After you go home, you should be able to do most of your normal activities, but you should avoid heavy lifting, sports, and swimming for a few weeks.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you are taking narcotic pain medicine during recovery, you might get constipated. Take a stool softener to prevent this problem.",
"     </p>",
"     <p>",
"      If you develop any the following symptoms in the weeks after surgery, call your doctor:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever or chills",
"       </li>",
"       <li>",
"        Redness or swelling around the cuts from your surgery",
"       </li>",
"       <li>",
"        Severe or cramping belly pain",
"       </li>",
"       <li>",
"        Bloating (feeling like your belly is full of gas)",
"       </li>",
"       <li>",
"        Yellow skin or eyes",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601218\">",
"      <span class=\"h1\">",
"       Will the surgery affect how my body breaks down food?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The surgery does not affect digestion very much. But about half the people who have surgery have mild symptoms afterward, including loose bowel movements, gas, or bloating. These symptoms usually get better.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7601233\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/29/8658?source=see_link\">",
"       Patient information: Gallstones (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/26/42401?source=see_link\">",
"       Patient information: Pancreatitis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/21/7507?source=see_link\">",
"       Patient information: Gallstones (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/36/41537?source=see_link\">",
"       Patient information: Acute pancreatitis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/45/26322?source=see_link\">",
"       Patient information: Chronic pancreatitis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/9/30865?source=see_link\">",
"       Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?1/56/1923?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16271 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1923=[""].join("\n");
var outline_f1_56_1923=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601103\">",
"      What is the gallbladder?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601120\">",
"      What is gallbladder removal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601137\">",
"      Why would a person have his or her gallbladder removed?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601152\">",
"      What happens before gallbladder removal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601169\">",
"      What are the benefits of gallbladder removal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601186\">",
"      What are the risks of gallbladder removal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601201\">",
"      What will my recovery be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601218\">",
"      Will the surgery affect how my body breaks down food?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7601233\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16271\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/37/27220\">",
"      Anatomy of the gallbladder",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29010\">",
"       Laparoscopic surgery (gallbladder removal)",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/36/41537?source=related_link\">",
"      Patient information: Acute pancreatitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/45/26322?source=related_link\">",
"      Patient information: Chronic pancreatitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/9/30865?source=related_link\">",
"      Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/21/7507?source=related_link\">",
"      Patient information: Gallstones (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/29/8658?source=related_link\">",
"      Patient information: Gallstones (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/26/42401?source=related_link\">",
"      Patient information: Pancreatitis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1924="Sodium thiosulfate: Pediatric drug information";
var content_f1_56_1924=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium thiosulfate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"    see \"Sodium thiosulfate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/63/11251?source=see_link\">",
"    see \"Sodium thiosulfate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Cyanide",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Extravasation",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"      see \"Sodium thiosulfate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Sodium thiosulfate is available as a 10% and 25% concentration and as part of various antidote kits or as a single product. Some dosing is concentration-dependent; verify product strength prior to dose calculation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cyanide poisoning: Note:",
"     </b>",
"     Usually given in conjunction with sodium nitrite. Administer sodium nitrite first, followed immediately by the administration of sodium thiosulfate. Monitor the patient for 24-48 hours following doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer&rsquo;s labeling: I.V.: Initial; 7",
"     <b>",
"      g/m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     ; maximum dose: 12.5",
"     <b>",
"      g",
"     </b>",
"     ; if repeat dosing is necessary due to symptom return, use 50% of original dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Alternate dosing (volume-based): I.V.: Initial: 25% solution: 1 mL/kg; maximum dose: 50 mL (12.5",
"     <b>",
"      g",
"     </b>",
"     ); if repeat dosing is necessary due to symptom return, use 50% of original dose.",
"     <b>",
"      Note:",
"     </b>",
"     Presented dose equates to 250 mg/kg  of sodium thiosulfate or 28-40 mL/",
"     <b>",
"      m",
"      <sup>",
"       2",
"      </sup>",
"     </b>",
"     of the 25% solution. Dosing is from Nithiodote&trade; manufacturer&rsquo;s labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: I.V.:  Initial: 12.5",
"     <b>",
"      g",
"     </b>",
"     (50 mL of a 25% solution); if repeat dosing is necessary due symptom return, use 50% of the original dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Mechlorethamine extravasation:",
"     </b>",
"     Children, Adolescents, and Adults: SubQ: 1/6 M (~4%) solution: Inject 2 mL for each mg of mechlorethamine suspected to have extravasated (Polovich, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     No dosage adjustment provided in the manufacturer&rsquo;s labeling; however, renal elimination of sodium thiosulfate is significant and risk of adverse effects may be increased in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     No dosage adjustment provided in the manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F222284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 100 mg/mL (10 mL); 250 mg/mL (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 250 mg/mL (50 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F222272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cyanide poisoning: I.V.: Inject slowly, over at least 10-20 minutes using a 0.22 micron in-line filter; rapid administration may cause hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mechlorethamine extravasation: SubQ: Inject into the extravasation site using &le;25-gauge needle; change needle with each injection (Polovich, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Preparation of compounded SubQ solution: Final concentration: 1/6 M (~4%) solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     If using 10 % sodium thiosulfate, add 4 mL to 6 mL SWI",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     If using 25% sodium thiosulfate, add 1.6 mL to 8.4 mL SWI",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1062293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store intact vials at 20&ordm;C to 25&ordm;C (68&ordm;F to 77&ordm;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Compounded SubQ solution: Store the 1/6 M (~4%) solution  at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F) (Polovich, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Treatment of cyanide poisoning [FDA approved in pediatric patients (age not specified) and adults]; has also been used for used in the management of mechlorethamine extravasation",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F222319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Disorientation, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, salty taste, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Bleeding time prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Warmth",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062301\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium thiosulfate or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The presence of sulfite hypersensitivity should not preclude the use of this medication. Due to the risk for serious adverse effects, use with caution in patients where the diagnosis of cyanide poisoning is uncertain. However, if clinical suspicion of cyanide poisoning is high, treatment should not be delayed. Treatment of cyanide poisoning should include decontamination and supportive therapy. Collection of pretreatment blood cyanide concentrations does not preclude administration and should not delay administration in the emergency management of highly suspected or confirmed cyanide toxicity. Pretreatment levels may be useful as postinfusion levels may be inaccurate. Monitor patients for return of symptoms for 24-48 hours; repeat treatment should be administered if symptoms return. Consider consultation with a poison control center at 1-800-222-1222.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Fire victims may present with both cyanide and carbon monoxide poisoning. In this scenario, sodium thiosulfate may be used alone to promote the clearance of cyanide. Due to the slow onset of action of sodium thiosulfate, may consider using hydroxocobalamin alone or in combination with sodium thiosulfate (Howland, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F222280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F222293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies of sodium thiosulfate. In general, medications used as antidotes should take into consideration the health and prognosis of the mother (Bailey, 2003).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F15235396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyanide poisoning: Monitor for at least 24-48 hours after administration; blood pressure and heart rate during and after infusion; hemoglobin/hematocrit; co-oximetry; serum lactate levels; venous-arterial PO",
"     <sub>",
"      2",
"     </sub>",
"     gradient; serum methemoglobin and oxyhemoglobin. Pretreatment cyanide levels may be useful diagnostically.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mechlorethamine extravasation: Monitor extravasation site for pain, blister formation, skin sloughing, arm/hand swelling/stiffness; monitor for fever, chills, or worsening pain",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cyanide toxicity: Serves as a sulfur donor in rhodanese-catalyzed formation of thiocyanate (much less toxic than cyanide)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mechlorethamine extravasation: Neutralizes the reactive species of mechlorethamine; reduces the formation of hydroxyl radicals",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thiosulfate: ~3 hours (Howland, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thiocyanate: ~3 hours; renal impairment: &le;9 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (~20% to 50% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bailey B, \"Are There Teratogenic Risks Associated With Antidotes Used in the Acute Management of Poisoned Pregnant Women?\"",
"      <i>",
"       Birth Defects Res A Clin Mol Teratol",
"      </i>",
"      , 2003, 67(2):133-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/56/1924/abstract-text/12769509/pubmed\" id=\"12769509\" target=\"_blank\">",
"        12769509",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Geller RJ, Barthold C, Saiers JA, et al, \"Pediatric Cyanide Poisoning: Causes, Manifestations, Management, and Unmet Needs,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2006, 118(5):2146-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/56/1924/abstract-text/17079589/pubmed\" id=\"17079589\" target=\"_blank\">",
"        17079589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gracia R and Shepherd G, \"Cyanide Poisoning and Its Treatment,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2004, 24(10):1358-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/56/1924/abstract-text/15628833/pubmed\" id=\"15628833\" target=\"_blank\">",
"        15628833",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hall AH, Dart R, and Bogdan G, &ldquo;Sodium Thiosulfate or Hydroxocobalamin for the Empiric Treatment of Cyanide Poisoning?&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2007, 49(6):806-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/56/1924/abstract-text/17098327/pubmed\" id=\"17098327\" target=\"_blank\">",
"        17098327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Howland MA, &ldquo;Antidotes in Depth: Sodium and Amyl Nitrite,&rdquo;",
"      <i>",
"       Goldfrank's Toxicologic Emergencies",
"      </i>",
"      , 9th ed, Nelson LS, Hoffman RS, Lewin NA, et al, eds, New York, NY: McGraw-Hill Companies, Inc, 2011, 1519-22.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Howland MA, &ldquo;Antidotes in Depth: Sodium Thiosulfate,&rdquo;",
"      <i>",
"       Goldfrank's Toxicologic Emergencies",
"      </i>",
"      , 9th ed, Nelson LS, Hoffman RS, Lewin NA, et al, eds, New York, NY: McGraw-Hill Companies, Inc, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?1/56/1924/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Polovich M, Whitford JN and Olsen M,",
"      <i>",
"       Chemotherapy and Biotherapy Guidelines and Reccomendations for Practice",
"      </i>",
"      , 3rd ed, Pittsburgh, PA: Oncology Nursing Society, 2009.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12800 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-D201336892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1924=[""].join("\n");
var outline_f1_56_1924=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062295\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062291\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222284\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222272\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062298\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062293\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062297\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222319\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062301\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062290\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300072\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223035\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222280\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222293\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15235396\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062289\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062300\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12800\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12800|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=related_link\">",
"      Sodium thiosulfate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/63/11251?source=related_link\">",
"      Sodium thiosulfate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1925="Bacitracin: Patient drug information";
var content_f1_56_1925=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bacitracin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     see \"Bacitracin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/63/33779?source=see_link\">",
"     see \"Bacitracin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F138673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Baciguent&reg; [OTC];",
"     </li>",
"     <li>",
"      BACiiM&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F138674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Baciguent&reg;;",
"     </li>",
"     <li>",
"      Baciject&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shot: May cause kidney function to get worse. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to avoid or treat skin infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691501",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat eye infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701580",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bacitracin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Eye:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697926",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bright lights may bother you. Wear sunglasses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Topical:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705387",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Eye ointment:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696126",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and to the side of affected eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694922",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gently pull down the lower lid and squeeze in how much the doctor told you to use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Release the lower eyelid and keep eyes closed for 1 to 2 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695617",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 10 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694431",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected part and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be covered with a bandage or dressing.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10023099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10023104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11580 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FBD0C7583D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1925=[""].join("\n");
var outline_f1_56_1925=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138673\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138674\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023094\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023096\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023095\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023100\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023101\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023103\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023098\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023099\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023104\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023105\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=related_link\">",
"      Bacitracin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/63/33779?source=related_link\">",
"      Bacitracin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1926="Tessier classification of facial clefts";
var content_f1_56_1926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tessier classification of facial clefts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 541px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kawamoto HK Jr, Cranofacial anomalies. In: Grab &amp; Smith's Plastic Surgery, 4th ed, Smith J, Aston S (Eds), Little, Brown, New York 1991. Copyright &copy; 1991 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1926=[""].join("\n");
var outline_f1_56_1926=null;
var title_f1_56_1927="Hepcidin regulatory pathways";
var content_f1_56_1927=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F64022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F64022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Hepcidin regulatory pathways",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 538px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of mechanisms activating hepcidin transcription. In the central part, BMP6 activates its type I and II receptors interacting with the co-receptor hemojuvelin on hepatocyte plasma membrane. This triggers the phosphorylation of SMAD1/5/8, which interacts with SMAD4; the transcriptional SMAD complex translocates to the nucleus to activate hepcidin transcription. On the left site, the potential role of HFE and TfR2 is shown. HFE binds TfR1 in competition with Tf-Fe2. High Tf-Fe2 levels display HFE that is free to bind TfR2. It is hypothesized that the HFE-TfR2 complex activates hepcidin, but the molecular mechanisms are unclear (indicated by the question mark). On the right site, IL-6, increased in inflammation, interacts with IL-6R to phosphorylate STAT3 that interacts with HAMP promoter to activate hepcidin transcription.",
"    <div class=\"footnotes\">",
"     BMP6: bone morphogenetic protein 6; BMPRI-II: bone morphogenetic protein type I and II receptors; HJV: hemojuvelin; HAMP: hepcidin antimicrobial peptide; Tf-Fe2: diferric transferrin; IL-6R: IL-6 receptor.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1927=[""].join("\n");
var outline_f1_56_1927=null;
var title_f1_56_1928="General principles of the management of variceal hemorrhage";
var content_f1_56_1928=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   General principles of the management of variceal hemorrhage",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Arun J Sanyal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1928/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/56/1928/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Active variceal hemorrhage accounts for about one-third of all deaths related to cirrhosis. There are four major issues related to the prevention and treatment of variceal hemorrhage:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prediction of patients at risk (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21446?source=see_link\">",
"       \"Prediction of variceal hemorrhage in patients with cirrhosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Prophylaxis against a first bleed (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/49/27418?source=see_link\">",
"       \"Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Treatment of an active bleed (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"       \"Treatment of active variceal hemorrhage\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Prevention of rebleeding (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17786?source=see_link\">",
"       \"Prevention of recurrent variceal hemorrhage in patients with cirrhosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The outcome of an episode of active hemorrhage depends upon the control of active bleeding and avoidance of the major complications associated with bleeding and its treatment. Establishing the correct diagnosis is also important. Other causes of upper gastrointestinal bleeding in patients with liver disease include peptic ulcer disease, Mallory-Weiss tear, portal hypertensive gastropathy, and gastric antral vascular ectasia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=see_link\">",
"     \"Major causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41865?source=see_link\">",
"     \"Uncommon causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency with which varices account for upper gastrointestinal bleeding in patients with cirrhosis is uncertain. Varices appeared to be the source of bleeding in 50 to 90 percent of cirrhotic patients with upper gastrointestinal bleeding in various reports, although a variety of other causes may also be responsible [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. In patients with cirrhosis, any upper gastrointestinal bleeding associated with hemodynamic changes requires endoscopic evaluation and should be considered to be variceal in origin until proven otherwise.",
"   </p>",
"   <p>",
"    This topic review will discuss the general principles involved in the initial management of the patient with an acute variceal hemorrhage. The treatment modalities directed specifically at stopping the bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The existing literature is confounded by the variable use of terminology across studies. As a result, several definitions were agreed upon during a consensus conference, which simplify evaluation of published studies and render new studies more comparable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Time zero, the time of admission to a medical care facility.",
"     </li>",
"     <li>",
"      Clinically significant bleeding, defined by a transfusion requirement of two units of blood or more within 24 hours of time zero together with a systolic blood pressure below 100 mmHg, a postural systolic change of more than 20 mmHg,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a pulse rate above 100",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      at time zero.",
"     </li>",
"     <li>",
"      Acute bleeding episode, which represents the events in the interval of 120 hours (5 days) from time zero. Bleeding during this time is considered to represent failure of therapy. Failure of therapy is defined by any of the following criteria:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fresh hematemesis or &gt;100 mL of blood in the nasogastric aspirate more than two hours after the start of a specific drug or endoscopic treatment",
"     </li>",
"     <li>",
"      Development of hypovolemic shock",
"     </li>",
"     <li>",
"      Drop in hemoglobin of &ge;3 gm within a 24 hour period",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Any bleeding occurring after initial hemostasis and more than 120 hours from time zero but less than six weeks is considered to represent early rebleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two distinct phases in the course of variceal hemorrhage: an acute phase and a later phase in which there is a high risk of recurrent bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/9\">",
"     9",
"    </a>",
"    ]. The acute phase starts with the onset of active hemorrhage (",
"    <a class=\"graphic graphic_picture graphicRef64026 \" href=\"UTD.htm?4/1/4127\">",
"     picture 1",
"    </a>",
"    ). Only 50 percent of patients with variceal hemorrhage stop bleeding spontaneously; this is quite different from the more than 90 percent spontaneous cessation rate in patients with other forms of upper gastrointestinal hemorrhage. Patients with Child class C cirrhosis and large, actively spurting varices are less likely to achieve spontaneous hemostasis (",
"    <a class=\"graphic graphic_table graphicRef78401 \" href=\"UTD.htm?8/21/8540\">",
"     table 1",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?27/26/28065?source=see_link\">",
"     calculator 1",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?28/28/29121?source=see_link\">",
"     calculator 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, a hepatic venous pressure gradient &gt;20 mmHg is associated with a greater risk of continued or recurrent bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/11\">",
"     11",
"    </a>",
"    ]. Active infection is associated with an increased risk of bleeding and multiorgan failure, which forms the basis for the recommended use of antibiotics in patients with variceal bleeding. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Infection and use of prophylactic antibiotics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Following cessation of active hemorrhage, there is a period of approximately six weeks in which there is a high risk of recurrent hemorrhage. The greatest risk is within the first 48 to 72 hours, and over 50 percent of all early rebleeding episodes occur within the first 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/12\">",
"     12",
"    </a>",
"    ]. Risk factors for early rebleeding include age greater than 60 years, renal failure, large varices, and severe initial bleeding as defined by a hemoglobin below 8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    at admission (",
"    <a class=\"graphic graphic_table graphicRef52618 \" href=\"UTD.htm?0/10/171\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/12\">",
"     12",
"    </a>",
"    ]. Survival during this period mirrors the risk of rebleeding and is directly related to the outcome of bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17786?source=see_link\">",
"     \"Prevention of recurrent variceal hemorrhage in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of bleeding and of death in patients who survive six weeks is similar to that in cirrhotic patients of equivalent severity who have never bled (",
"    <a class=\"graphic graphic_figure graphicRef70212 \" href=\"UTD.htm?22/5/22621\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. One-year survival in those who survive two weeks after a variceal bleed is approximately 52 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/9\">",
"     9",
"    </a>",
"    ]. Survival appears to have increased since the 1980s due to a decrease in short-term mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Acute bleeding from varices is associated with approximately 15 to 20 percent 30-day mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES OF MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three primary goals of management during the active bleeding episode: hemodynamic resuscitation; prevention and treatment of complications; and treatment of bleeding (",
"    <a class=\"graphic graphic_table graphicRef55338 \" href=\"UTD.htm?36/12/37067\">",
"     table 3",
"    </a>",
"    ). All three need to be pursued simultaneously and often require the coordinated care of a hepatologist, critical care clinician, critical care nurse, surgeon, and interventional radiologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hemodynamic resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restoration of the intravascular volume should be aggressively managed with large bore peripheral intravenous lines or a central line. Blood loss should be replaced by packed cells and clotting factors should be replaced as needed. Platelet counts often drop within the first 48 hours after a bleed and may necessitate platelet transfusions if values below",
"    <span class=\"nowrap\">",
"     50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    occur in an actively bleeding patient. In extreme settings, correction of the coagulopathy is necessary but cannot be adequately with FFP, particularly in patients who are severely volume overloaded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/33/9752?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical use of plasma components\", section on 'Fresh frozen plasma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients must be monitored carefully to avoid overtransfusion with volume overload because of the risk of rebound portal hypertension and induction of rebleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. Those receiving large volumes of blood products should be monitored for a reduction in the serum ionized calcium concentration (due to citrate binding of ionized calcium) and thrombocytopenia; these abnormalities should be corrected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=see_link\">",
"     \"Massive blood transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Recombinant factor VIIa",
"    </span>",
"    &nbsp;&mdash;&nbsp;It may not be possible to correct the coagulopathy adequately with FFP, particularly in patients who are severely volume overloaded. Small pilot studies have demonstrated that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/42/30373?source=see_link\">",
"     recombinant human factor VIIa",
"    </a>",
"    (rFVIIa) has been associated with improvement or normalization of the serum prothrombin time and control of bleeding in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/21-27\">",
"     21-27",
"    </a>",
"    ]. However, at least two randomized controlled trials and a meta-analysis of those trials failed to demonstrate a clear benefit of recombinant factor VII in active variceal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Thus, the role of recombinant factor VIIa in management of bleeding awaits further clarification before it can be recommended for routine clinical practice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31962?source=see_link\">",
"     \"Therapeutic uses of recombinant coagulation factor VIIa\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of pharmacologic therapy (eg, vasopressin, somatostatin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    ) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Prevention and management of complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications related to bleeding and to the treatment of bleeding contribute substantially to mortality from active hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/30\">",
"     30",
"    </a>",
"    ]. While hemostasis is almost invariably achieved, many patients succumb to the complications that develop following admission. Thus, prevention, monitoring, and treatment are critically important. The principal complications that cause death are aspiration pneumonia, sepsis, acute-on-chronic liver failure, hepatic encephalopathy, and renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/10,30,31\">",
"     10,30,31",
"    </a>",
"    ]. It is not unusual for multiple complications to develop simultaneously.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endotracheal intubation to protect the airway can be considered in patients with massive bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/32\">",
"     32",
"    </a>",
"    ]. However, whether it is protective against aspiration pneumonia is unclear. One study suggested that it may increase the risk [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/33\">",
"     33",
"    </a>",
"    ]. It is the author's practice to protect the airway in cases with severe hematemesis prior to endoscopy because it also facilitates the performance of endoscopy and endoscopic therapy, especially if the patient is intoxicated, agitated, or unable to protect his or her airway.",
"   </p>",
"   <p>",
"    Whether placement of a nasogastric tube can help prevent aspiration has not been well studied. However, a nasogastric tube can help decompress the stomach and assist in clearing it of blood for subsequent endoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Infection and use of prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial infections are present in up to 20 percent of patients with cirrhosis who are hospitalized with gastrointestinal bleeding; up to an additional 50 percent develop an infection while hospitalized [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/34\">",
"     34",
"    </a>",
"    ]. Such patients have increased mortality. The most common sites are urinary tract infections (approximately 12 to 29 percent), spontaneous bacterial peritonitis (7 to 23 percent), respiratory infections (6 to 10 percent), and primary bacteremia (4 to 11 percent).",
"   </p>",
"   <p>",
"    Multiple trials evaluating the effectiveness of prophylactic antibiotics in cirrhotic patients hospitalized for bleeding suggest an overall reduction in infectious complications and possibly decreased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. Antibiotics may also reduce the risk of recurrent bleeding in hospitalized patients who bled from esophageal varices [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the optimal choice of antibiotic, duration of therapy, and selection of patients who might benefit most remains unclear. Although a consistent benefit was demonstrated, the trials supporting antibiotic prophylaxis included only a small number of patients with varying severity of liver disease and different causes of bleeding (about two-thirds were variceal), compared multiple different antibiotic regimens, and many had important methodologic limitations. A systematic review that included eight placebo-controlled trials with a total of 864 patients found the antibiotics were associated with a significant reduction in mortality (RR 0.75, 95% CI 0.55 to 0.95) and bacterial infections (RR 0.40, 95% CI 0.32 to 0.51) including bacteremia, pneumonia, spontaneous bacterial peritonitis, and urinary tract infections [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/34,40\">",
"     34,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent meta-analysis of 12 trials that compared antibiotic prophylaxis with placebo or no intervention found a benefit of prophylactic antibiotic use with regard to mortality (relative risk [RR] 0.79, 95% confidence interval [CI] 0.63-0.98), mortality from bacterial infections (RR 0.43, 95% CI 0.19-0.97), bacterial infections (RR 0.35, 95% CI 0.26-0.47), rebleeding (RR 0.53, 95% CI 0.38-0.74), and days of hospitalization (mean difference -1.9 days, 95% CI -3.8-0.02) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A reasonable conclusion from these data is that patients with cirrhosis who present with upper GI bleeding (from varices or other causes) should be given prophylactic antibiotics, preferably before endoscopy (although effectiveness has also been demonstrated when given after endoscopy). The benefit to antibiotics is probably greater in patients with advanced liver disease (Child Pugh class B and C) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/36\">",
"     36",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef78401 \" href=\"UTD.htm?8/21/8540\">",
"     table 1",
"    </a>",
"    ) but all cirrhotic patients should be considered eligible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of active variceal hemorrhage\", section on 'Prophylactic antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal choice of antibiotics and duration of therapy is unclear since a benefit was detected from most of the studied regimens, which differed in the choice of antibiotics, their spectrum of activity, and duration of treatment ranging from a single dose up to 10 days. Most of the studies included a quinolone in doses ranging from 400 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35776?source=see_link\">",
"     ofloxacin",
"    </a>",
"    , 400 to 800 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/9/16536?source=see_link\">",
"     norfloxacin",
"    </a>",
"    , and 400 to 1000 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    . Other regimens included cephalosporins, a quinolone given with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    , nonabsorbable antibiotics, and imipenem-cilastin. We tend to use a broad spectrum antibiotic such as intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    for seven days), which was superior to norfloxacin in a randomized controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/42\">",
"     42",
"    </a>",
"    ]. For patients being discharged before seven days, we transition to oral norfloxacin (400 mg twice daily) to complete seven days of antibiotics.",
"   </p>",
"   <p>",
"    An important consideration in the choice of antibiotics should be local patterns of antibiotic resistance; quinolone resistance, for example, has become an increasing problem in cirrhotic patients in some centers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/38\">",
"     38",
"    </a>",
"    ]. The possibility of quinolone resistance is a particular concern in patients who have been receiving prophylactic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/9/16536?source=see_link\">",
"     norfloxacin",
"    </a>",
"    for the prevention of spontaneous bacterial peritonitis. A randomized controlled trial in a setting with high quinolone resistance found a significantly higher probability of developing proved or possible infections (33 versus 11 percent) or spontaneous bacterial peritonitis (12 versus 2 percent) in patients who had been randomized to oral norfloxacin compared with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Guidelines for antibiotics have been issued by the American Association for the Study of Liver Diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Short-term (maximum 7 days) antibiotic prophylaxis should be instituted in any patient with cirrhosis and GI hemorrhage. Oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/9/16536?source=see_link\">",
"       norfloxacin",
"      </a>",
"      (400 mg twice daily) or intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (in patients in whom oral administration is not possible) is the recommended antibiotic.",
"     </li>",
"     <li>",
"      In patients with advanced cirrhosis, intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      may be preferable, particularly in centers with a high prevalence of quinolone-resistant organisms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Hepatic encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic encephalopathy should be managed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    and an aggressive search for potentially reversible factors other than gastrointestinal bleeding that may contribute to the encephalopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=see_link\">",
"     \"Hepatic encephalopathy in adults: Treatment\"",
"    </a>",
"    .) Hypokalemia may be a particular problem because it can promote the development of hepatic encephalopathy via increased renal ammonia production [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/44\">",
"     44",
"    </a>",
"    ]. Metabolic alkalosis, if the hypokalemia is induced by diuretics or vomiting, may also contribute by promoting the movement of ammonia across the blood-brain barrier. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6245?source=see_link\">",
"     \"Hypokalemia-induced renal dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of renal failure (due either to acute tubular necrosis or to precipitation of the hepatorenal syndrome) can be minimized by appropriate volume replacement, and avoidance of aminoglycosides and mismatched transfusions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcoholic subjects should receive thiamine and be monitored for withdrawal symptoms. Nutritionally depleted subjects may develop hypophosphatemia and hypokalemia, especially after dextrose infusions which raise serum insulin concentrations; insulin drives both phosphate and potassium into the cells [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1928/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/42/28324?source=see_link\">",
"     \"Hypophosphatemia in the alcoholic patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment of active bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of active bleeding is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/60/24515?source=see_link\">",
"       \"Patient information: GI bleed (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/9/12434?source=see_link\">",
"       \"Patient information: Screening for esophageal varices (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are two distinct phases in the course of variceal hemorrhage: an acute phase and a later phase in which there is a high risk of recurrent bleeding. Only 50 percent of patients with variceal hemorrhage stop bleeding spontaneously; this is quite different from the more than 90 percent spontaneous cessation rate in patients with other forms of upper gastrointestinal hemorrhage. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following cessation of active hemorrhage, there is a period of approximately six weeks in which there is a high risk of recurrent hemorrhage. The greatest risk is within the first 48 to 72 hours, and over 50 percent of all early rebleeding episodes occur within the first 10 days. The risk of bleeding and of death in patients who survive six weeks is similar to that in patients with cirrhosis of equivalent severity who have never bled (",
"      <a class=\"graphic graphic_figure graphicRef70212 \" href=\"UTD.htm?22/5/22621\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are three primary goals of management during the active bleeding episode: hemodynamic resuscitation, prevention and treatment of complications, and treatment of bleeding (",
"      <a class=\"graphic graphic_table graphicRef55338 \" href=\"UTD.htm?36/12/37067\">",
"       table 3",
"      </a>",
"      ). All three need to be pursued simultaneously and often require the coordinated care of a hepatologist, critical care clinician, critical care nurse, surgeon, and interventional radiologist. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'General principles of management'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"       \"Treatment of active variceal hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/1\">",
"      Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am 1996; 80:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/2\">",
"      Dave P, Romeu J, Messer J. Upper gastrointestinal bleeding in patients with portal hypertension: a reappraisal. J Clin Gastroenterol 1983; 5:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/3\">",
"      Sutton FM. Upper gastrointestinal bleeding in patients with esophageal varices. What is the most common source? Am J Med 1987; 83:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/4\">",
"      Naparstek Y, Raachmilewitz D. UGI bleeding in nonalcoholic populations with portal hypertension. J Clin Gastroenterol 1080; 2:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/5\">",
"      Schoppe LE, Roark GD, Patterson M. Acute upper gastrointestinal bleeding in patients with portal hypertension: a correlation of endoscopic findings with etiology. South Med J 1983; 76:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/6\">",
"      Buccino RV, Bogliolo G, Ferrara M, et al. Endoscopic approach to patients with portal hypertension: a complex diagnosis. A retrospective study based on 10 years' experience. Surg Endosc 1990; 4:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/7\">",
"      Odelowo OO, Smoot DT, Kim K. Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc 2002; 94:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/8\">",
"      de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/9\">",
"      Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/10\">",
"      Prandi D, Rueff B, Roche-Sicot J, et al. Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt. Am J Surg 1976; 131:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/11\">",
"      Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/12\">",
"      de Franchis R, Primignani M. Why do varices bleed? Gastroenterol Clin North Am 1992; 21:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/13\">",
"      El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95:3566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/14\">",
"      Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/15\">",
"      D'Amico G, De Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/16\">",
"      Kravetz D, Bosch J, Arderiu M, et al. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 1989; 9:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/17\">",
"      Cerqueira RM, Andrade L, Correia MR, et al. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol 2012; 24:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/18\">",
"      Krige JE, Kotze UK, Distiller G, et al. Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg 2009; 33:2127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/19\">",
"      Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/20\">",
"      McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut 1995; 36:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/21\">",
"      Shami VM, Hespenheide EE, Macik BG, et al. Recombinant activated factor VII in fulminant liver failure: Complete but transient correction of the coagulopathy (abstract). Hepatology 2000; 32:397A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/22\">",
"      Chuansumrit A, Chantarojanasiri T, Isarangkura P, et al. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2000; 11 Suppl 1:S101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/23\">",
"      N&eacute;grier C, Lienhart A. Overall experience with NovoSeven. Blood Coagul Fibrinolysis 2000; 11 Suppl 1:S19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/24\">",
"      Kalici��ski P, Kami��ski A, Drewniak T, et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 1999; 31:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/25\">",
"      Thabut D, de Franchis R, Bendsten F, et al. Efficacy of activated recombinant factor VII (RFVIIA; Novoseven&reg;) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial (abstract). J Hepatol 2003; 38 (Suppl):13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/26\">",
"      Ejlersen E, Melsen T, Ingerslev J, et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 2001; 36:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/27\">",
"      Bosch J, Thabut D, Bendtsen F, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004; 127:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/28\">",
"      Bosch J, Thabut D, Albillos A, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 2008; 47:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/29\">",
"      Mart&iacute;-Carvajal AJ, Karakitsiou DE, Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2012; 3:CD004887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/30\">",
"      D'Amico G, Morabito A, Pagliaro L. Six week prognostic indicators in upper gastrointestinal hemorrhage in cirrhotics. Front Gastrointest Res 1986; 9:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/31\">",
"      Garden OJ, Motyl H, Gilmour WH, et al. Prediction of outcome following acute variceal haemorrhage. Br J Surg 1985; 72:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/32\">",
"      Rudolph SJ, Landsverk BK, Freeman ML. Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage. Gastrointest Endosc 2003; 57:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/33\">",
"      Koch DG, Arguedas MR, Fallon MB. Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy. Dig Dis Sci 2007; 52:2225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/34\">",
"      Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002; :CD002907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/35\">",
"      Soriano G, Guarner C, Tom&aacute;s A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/36\">",
"      Pauwels A, Mostefa-Kara N, Debenes B, et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/37\">",
"      Bernard B, Grang&eacute; JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/38\">",
"      Fern&aacute;ndez J, Navasa M, G&oacute;mez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/39\">",
"      Hou MC, Lin HC, Liu TT, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004; 39:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/40\">",
"      Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003; 38:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/41\">",
"      Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther 2011; 34:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/42\">",
"      Fern&aacute;ndez J, Ruiz del Arbol L, G&oacute;mez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006; 131:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/43\">",
"      Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/44\">",
"      Artz SA, Paes IC, Faloon WW. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy. Gastroenterology 1966; 51:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1928/abstract/45\">",
"      Knochel JP. Hypophosphatemia in the alcoholic. Arch Intern Med 1980; 140:613.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1254 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-188.40.116.55-F65976BBC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1928=[""].join("\n");
var outline_f1_56_1928=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GENERAL PRINCIPLES OF MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hemodynamic resuscitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Recombinant factor VIIa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Prevention and management of complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Infection and use of prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Hepatic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Renal failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment of active bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1254\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1254|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/5/22621\" title=\"figure 1\">",
"      Relative mortality variceal bleed",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1254|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/1/4127\" title=\"picture 1\">",
"      Bleeding esoph varix Endosc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1254|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/21/8540\" title=\"table 1\">",
"      Child Pugh classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/10/171\" title=\"table 2\">",
"      Risk recurrent variceal bleed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/12/37067\" title=\"table 3\">",
"      Supportive care variceal bleed",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?27/26/28065?source=related_link\" title=\"calculator 1\">",
"      Calculator: Child Pugh classification for severity of liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?28/28/29121?source=related_link\" title=\"calculator 2\">",
"      Calculator: Child Pugh classification for severity of liver disease (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/33/9752?source=related_link\">",
"      Clinical use of plasma components",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=related_link\">",
"      Hepatic encephalopathy in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6245?source=related_link\">",
"      Hypokalemia-induced renal dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/42/28324?source=related_link\">",
"      Hypophosphatemia in the alcoholic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=related_link\">",
"      Major causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=related_link\">",
"      Massive blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/60/24515?source=related_link\">",
"      Patient information: GI bleed (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/9/12434?source=related_link\">",
"      Patient information: Screening for esophageal varices (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21446?source=related_link\">",
"      Prediction of variceal hemorrhage in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17786?source=related_link\">",
"      Prevention of recurrent variceal hemorrhage in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/49/27418?source=related_link\">",
"      Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31962?source=related_link\">",
"      Therapeutic uses of recombinant coagulation factor VIIa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=related_link\">",
"      Treatment and prophylaxis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=related_link\">",
"      Treatment of active variceal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41865?source=related_link\">",
"      Uncommon causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1929="Endoscopic ultrasound in the staging of exocrine pancreatic cancer";
var content_f1_56_1929=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endoscopic ultrasound in the staging of exocrine pancreatic cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Frank G Gress, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1929/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/56/1929/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exocrine pancreatic cancer is a common cause of cancer-related death in the United States and is second only to colorectal cancer as a cause of digestive cancer-related death [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Surgical resection offers the only potential cure, but because of the late presentation of the disease, only 10 to 15 percent of patients are candidates for pancreatectomy, and five-year survival rates are very low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=see_link\">",
"     \"Epidemiology and risk factors for exocrine pancreatic cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/34/8746?source=see_link\">",
"     \"Surgery in the treatment of exocrine pancreatic cancer and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main obstacles to potentially curative resection are the presence of distant metastases",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    invasion of nearby major vascular structures. A variety of studies are available for preoperative diagnosis and staging of pancreatic cancer, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transabdominal ultrasound",
"     </li>",
"     <li>",
"      Abdominal computed tomography",
"     </li>",
"     <li>",
"      Magnetic resonance imaging",
"     </li>",
"     <li>",
"      Endoscopic retrograde cholangiopancreatography",
"     </li>",
"     <li>",
"      Positron emission tomography",
"     </li>",
"     <li>",
"      Endoscopic ultrasonography",
"     </li>",
"     <li>",
"      Angiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the role of endoscopic ultrasound in the staging of pancreatic cancer. The general approach to the diagnosis and staging of pancreatic cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technical aspects of performing endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration or biopsy are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/43/8884?source=see_link\">",
"     \"Endoscopic ultrasound: Normal pancreaticobiliary anatomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"     \"Endoscopic ultrasound guided trucut biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staging patients with pancreatic cancer includes determining the tumor-node-metastasis (TNM) stage (",
"    <a class=\"graphic graphic_table graphicRef62155 \" href=\"UTD.htm?42/32/43532\">",
"     table 1",
"    </a>",
"    ), as well as evaluating for vascular invasion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple imaging modalities, including endoscopic ultrasound (EUS), are available for staging pancreatic cancer. EUS is typically used to further evaluate patients with nonmetastatic disease that appears resectable on initial imaging (eg, computed tomography or magnetic resonance imaging) (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Clinical algorithm'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Goal of staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of preoperative staging is to identify patients who might benefit from surgery, while avoiding surgery in patients with locally advanced or metastatic disease. However, even with efforts to establish resectability preoperatively, many patients have unresectable tumors at surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     TNM staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic cancer is staged using the tumor-node-metastasis (TNM) system (",
"    <a class=\"graphic graphic_table graphicRef62155 \" href=\"UTD.htm?42/32/43532\">",
"     table 1",
"    </a>",
"    ), which underwent revision in 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/4\">",
"     4",
"    </a>",
"    ]. EUS is useful for tumor and node staging, while alternative imaging modalities, such as CT or magnetic resonance imaging, are required for metastasis staging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link&amp;anchor=H18017084#H18017084\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Staging system and the staging workup'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, EUS is more accurate than CT for T-staging of smaller tumors, whereas CT is more accurate than EUS for larger tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/5\">",
"     5",
"    </a>",
"    ]. EUS appears to be as accurate as helical CT and multidetector row CT for N-staging [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Evaluation of vascular invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence or absence of vascular invasion is a major determinant of tumor resectability. However, vascular invasion does not automatically preclude resection since some vessels involved with the tumor can be resected and reconstructed. Thus, it is important to know whether vascular invasion is present, and if it is, to determine the specific anatomic location and the degree of vascular invasion.",
"   </p>",
"   <p>",
"    Vascular invasion is probable if any of the following is present [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peripancreatic venous collaterals in an area of a mass that obliterates the normal anatomic location of a major portal confluence vessel",
"     </li>",
"     <li>",
"      Tumor within the vessel lumen",
"     </li>",
"     <li>",
"      Abnormal vessel contour or irregular wall with loss of the vessel-parenchymal sonographic interface",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ACCURACY OF EUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported accuracy of endoscopic ultrasound (EUS) for TNM staging and for determining vascular invasion is highly variable among studies. Some studies show superiority to other imaging modalities, while other studies show equivalent or even inferior results for EUS. Given this variability, EUS is typically used as a complementary imaging modality in patients who have apparently resectable disease on computed tomography (CT) or magnetic resonance imaging (MRI). (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Clinical algorithm'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several factors, such as the experience of the endosonographer and the endosonographer's knowledge of prior diagnostic imaging studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/8\">",
"     8",
"    </a>",
"    ], may influence the staging accuracy of EUS. The endosonographer should have performed at least 100 EUS examinations for pancreatic tumor staging [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The type of instrument used does not appear to influence staging accuracy. Both radial and linear array EUS instruments perform equally well, although the latter has the advantage of permitting fine-needle aspiration (FNA) biopsies to be obtained (see",
"    <a class=\"local\" href=\"#H16\">",
"     'EUS-FNA'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     TNM stage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported accuracy of EUS for T-staging is highly variable, ranging from 63 to 94 percent, with reported accuracies for N-staging ranging from 44 to 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/3,8,10,12-19\">",
"     3,8,10,12-19",
"    </a>",
"    ]. Comparing studies for T-staging is difficult because of changes in T-staging criteria over time. Two of the more recent studies showed an accuracy of 63 and 67 percent for T-staging and 67 and 44 percent for N-staging [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vascular invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported sensitivity of EUS for detecting vascular invasion has varied widely, with estimates ranging from 50 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/20\">",
"     20",
"    </a>",
"    ]. A meta-analysis of 29 studies showed that EUS had high specificity (90 percent) but only moderate sensitivity (73 percent) for detecting vascular invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Analyses have also shown that both sensitivity and specificity have decreased over time [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/20\">",
"     20",
"    </a>",
"    ]. When comparing the time period of 1988 to 1994 with the period of 2000 to 2005, the pooled sensitivity decreased from 90 to 65 percent, and the pooled specificity decreased from 96 to 86 percent. The authors suggest that the decreasing sensitivity seen over time may reflect smaller numbers of patients in earlier studies.",
"   </p>",
"   <p>",
"    EUS may not be as accurate in excluding vascular invasion in patients with small pancreatic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/20\">",
"     20",
"    </a>",
"    ]. However, EUS is superior to other imaging modalities, such as CT and transabdominal ultrasound, for detecting vascular invasion in tumors that are smaller than 3 cm (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55783 \" href=\"UTD.htm?33/11/33971\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The accuracy of EUS also varies with the vessel being examined. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/8,9,23\">",
"     8,9,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     COMPARISON OF EUS WITH OTHER IMAGING TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have compared endoscopic ultrasound (EUS) with helical computed tomography (CT), multidetector row CT (MDR-CT), magnetic resonance imaging (MRI), and angiography for initial diagnosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    staging of pancreatic cancer. However, direct comparison of the data can be difficult because of differences in inclusion criteria and reference standards. The imaging modalities chosen to stage patients with pancreatic cancer should take into account the studies' accuracy as well as local expertise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Helical CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have compared the accuracy of EUS with helical CT for the evaluation of pancreatic cancer resectability [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/6,18,19,24-29\">",
"     6,18,19,24-29",
"    </a>",
"    ]. However, the studies are heterogeneous, and most had methodologic flaws.",
"   </p>",
"   <p>",
"    These limitations were highlighted in a systematic review that examined 11 studies with 678 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/6\">",
"     6",
"    </a>",
"    ]. Only three studies met all but one of the quality criteria. The most important and frequent study limitations were lack of a consecutive series of patients and biased patient selection for surgery that potentially affected validity. The older studies included in that review suggested that EUS was superior to CT for staging and determining vascular invasion. However, the more recent studies found that helical CT was more accurate than EUS for T-staging (73 versus 63 percent) and was equivalent for N-staging (62 to 63 percent versus 65 to 69 percent). EUS and CT were also equivalent with regard to detecting vascular invasion. More prospective studies are needed before definitive conclusions can be made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Multidetector row CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT scanners with multiple rows of detectors permit imaging of larger volumes of tissue, while acquiring both arterial and venous phases in shorter periods of time [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/18,30\">",
"     18,30",
"    </a>",
"    ]. MDR-CT has improved the evaluation of the main pancreatic duct and the detection of small tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a few studies comparing EUS with MDR-CT for detecting and staging pancreatic cancer are available. In a report of 80 patients who underwent EUS for pancreatic cancer, EUS was superior to MDR-CT for tumor detection (sensitivity 98 versus 86 percent) and primary T-staging (accuracy 67 versus 41 percent), but similar for nodal staging (accuracy 44 versus 47 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/19\">",
"     19",
"    </a>",
"    ]. Fifty-three patients underwent surgery and 25 were found to have resectable tumors. EUS and MDR-CT correctly identified 88 and 92 percent of the resectable tumors. Of the 28 surgical patients with unresectable tumors, EUS and MDR-CT correctly identified the tumors as being unresectable in 68 and 64 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have compared the accuracy of EUS and angiography for determining vascular invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/8,18,23,25,32\">",
"     8,18,23,25,32",
"    </a>",
"    ]. Although the results vary, EUS appears to be as accurate or more accurate for determining vascular invasion, except for tumors that invade the superior mesenteric vein. The following examples illustrate these points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study included 45 patients with pancreatic cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/23\">",
"       23",
"      </a>",
"      ]. Several EUS criteria for vascular invasion were studied, the most accurate of which was the presence of an irregular venous wall (accuracy 87 percent). However, the sensitivity of wall irregularity for detecting vascular invasion was only 47 percent, due in large part to difficulty in detecting invasion of the superior mesenteric vein (sensitivity of 17 percent). In 28 patients who underwent surgical exploration, negative resection margins were attained in 86 percent when both tests were used preoperatively, 78 percent when EUS was used without angiography, and 60 percent when only angiography was used.",
"     </li>",
"     <li>",
"      Higher sensitivities were noted in a report of 21 patients with pancreatic cancer who underwent EUS and angiography prior to an attempt at curative resection [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/32\">",
"       32",
"      </a>",
"      ]. EUS was significantly more sensitive than angiography for detecting vascular invasion (86 versus 21 percent) with equivalent specificity (71 percent for both).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies comparing EUS with MRI suggest that EUS may be more sensitive for detecting small tumors, while providing complementary information regarding resectability [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/15,18,33,34\">",
"     15,18,33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective study focused on 63 patients with pancreatic cancer who underwent both examinations, using surgical results as the gold standard [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/33\">",
"     33",
"    </a>",
"    ]. The tumor was resectable in 36 patients (57 percent). The sensitivities of EUS and MRI for determining resectability were 61 and 73 percent, respectively. EUS and MRI both predicted resectability in 18 patients, of whom 16 (89 percent) were found to be resectable at the time of surgery. Both studies predicted unresectability in 17 patients, of whom 13 (76 percent) were unresectable at the time of surgery.",
"   </p>",
"   <p>",
"    In a prospective study of 48 patients who were staged with EUS and MRI prior to surgery, the correlation between EUS and MRI was fair (kappa 0.42), with agreement in the patient's staging seen in 74 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/35\">",
"     35",
"    </a>",
"    ]. EUS understaged 13 patients (27 percent), whereas MRI understaged 12 (25 percent). Only one patient was overstaged by EUS, and none were overstaged by MRI. MRI was more likely to report metastatic disease or arterial involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     PET scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron emission tomography (PET) scanning has been studied in the evaluation of patients with a variety of malignancies, including pancreatic cancer. PET scanning has a high sensitivity (approximately 90 percent) for detecting pancreatic cancer, but only moderate specificity (approximately 70 percent) since benign inflammatory lesions can mimic cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Another pitfall of PET is that it provides limited anatomic information, which can be overcome by combining it with CT.",
"   </p>",
"   <p>",
"    The role of PET scanning for the staging of pancreatic cancer requires further investigation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'PET scanning'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EUS-FNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) may help in the diagnosis and staging of pancreatic cancer in multiple ways. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    EUS-FNA can be used to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biopsy lesions that are too small to be characterized by computed tomography (CT) or magnetic resonance imaging (MRI) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Biopsy lesions that are too encased by surrounding vascular structures to permit safe percutaneous biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Demonstrate malignant invasion of lymph nodes located in the celiac, para-aortic, retroduodenopancreatic, or superior mesenteric regions [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/39\">",
"       39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Biopsy suspected small metastases in the left lobe of the liver [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Diagnose carcinomatosis through sampling of ascitic fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for EUS-FNA in patients with pancreatic cancer are controversial. It is generally agreed that histologic confirmation is helpful for planning chemotherapy or radiotherapy in patients who have distant metastases, are poor surgical candidates, or have advanced locoregional disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39114?source=see_link\">",
"     \"Chemotherapy for advanced exocrine pancreatic cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33370?source=see_link\">",
"     \"Management of locally advanced and borderline resectable exocrine pancreatic cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of EUS-guided FNA is more controversial in patients who are good surgical candidates with pancreatic cancer that appears to be resectable on other imaging studies. The traditional approach in such patients has been surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link&amp;anchor=H2363341#H2363341\">",
"     \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Diagnostic algorithm and need for preoperative biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In such patients, indications for EUS-FNA currently include [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/3,24,42,43\">",
"     3,24,42,43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ruling out other types of malignancy involving the pancreas that can mimic adenocarcinoma (eg, lymphoma and small cell carcinoma, metastatic disease, and gastrointestinal neuroendocrine tumors), as well as non-malignant processes, such as autoimmune or chronic pancreatitis.",
"     </li>",
"     <li>",
"      Assisting with surgical planning (eg, a more limited resection may be possible in patients with neuroendocrine tumors).",
"     </li>",
"     <li>",
"      Confirming the diagnosis in patients who want verification prior to surgery. However, as noted in the next section, a negative result does not exclude malignancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Accuracy of EUS-FNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS-FNA is technically successful in 90 to 95 percent of procedures, with high sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/3\">",
"     3",
"    </a>",
"    ]. A meta-analysis of 15 studies with 1860 patients found that overall, the sensitivity of EUS-FNA for pancreatic cancer was 92 percent, and the specificity was 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/44\">",
"     44",
"    </a>",
"    ]. In a second meta-analysis that included 41 studies with 4766 patients, the pooled sensitivity of EUS-FNA for diagnosing the correct etiology for a solid pancreatic mass was 89 percent, with a specificity of 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The accuracy, which is defined as the proportion of all test results (both positive and negative) that are correct, appears to be lower in the setting of chronic pancreatitis (74 versus 91 percent in one report) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/46\">",
"     46",
"    </a>",
"    ], particularly in patients with obstructive jaundice [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefits of EUS-guided FNA are illustrated by a study of 559 patients undergoing EUS-guided FNA for evaluation of pancreatic masses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/48\">",
"     48",
"    </a>",
"    ]. In that study, when using strict cytologic criteria, the sensitivity for EUS-guided FNA diagnosing pancreatic adenocarcinoma was 77 percent, with a specificity of 99 percent. When patients with atypical or suspicious cytologies were reclassified as positive for malignancy, the sensitivity increased to 93 percent, without a change in the specificity.",
"   </p>",
"   <p>",
"    The accuracy of EUS-FNA can improve with additional FNA passes and on-site histologic interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. In one report, the presence of a cytopathologist in attendance for all aspiration procedures was associated with a high degree of accuracy (95 percent) in diagnosing pancreatic cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/49\">",
"     49",
"    </a>",
"    ]. The absence of a cytopathologist during the EUS-FNA procedure required an average of at least five to six passes from the pancreatic mass to ensure adequate cellularity. In another study, there was a high yield from only two FNA passes when the samples were examined both by histology and cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/51\">",
"     51",
"    </a>",
"    ]. In that study, cytopathologists were not on-site during the procedure.",
"   </p>",
"   <p>",
"    The size of the needle used for FNA may also be important. In a meta-analysis of eight studies with 1292 patients, the sensitivity of FNA using a 25-gauge needle was higher than that for a 22-gauge needle (1 versus 0.85) with similar specificity (0.97 versus 0.93) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     EUS-FNA versus percutaneous image-guided FNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few studies comparing EUS-FNA to alternative sampling techniques such as ERCP, CT-guided",
"    <span class=\"nowrap\">",
"     FNA/biopsy,",
"    </span>",
"    or transabdominal ultrasound (US)-guided",
"    <span class=\"nowrap\">",
"     FNA/biopsy",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/53-57\">",
"     53-57",
"    </a>",
"    ]. A prospective, randomized crossover trial comparing EUS-FNA with transabdominal",
"    <span class=\"nowrap\">",
"     US/CT-guided",
"    </span>",
"    FNA in the diagnosis of pancreatic cancer found no statistical difference between percutaneous and EUS-guided approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/53\">",
"     53",
"    </a>",
"    ]. Although both approaches were most accurate when the average lesion was at least 3 cm in diameter, EUS-FNA was more useful when the",
"    <span class=\"nowrap\">",
"     US/CT",
"    </span>",
"    examination was unable to discern small, discrete lesions.",
"   </p>",
"   <p>",
"    In addition to improved diagnosis of small lesions, EUS-FNA compared with",
"    <span class=\"nowrap\">",
"     US/CT-guided",
"    </span>",
"    FNA is associated with reductions in the risk of needle-tract seeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/58\">",
"     58",
"    </a>",
"    ], the risk of peritoneal carcinomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/59\">",
"     59",
"    </a>",
"    ], and cost [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Cost-effectiveness'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Molecular genetic analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of molecular genetic analysis (eg, assay for K-ras or p53 gene mutations by RT-PCR or restriction length polymorphisms, promoter methylation of tumor suppressor genes, differential protein expression [proteomics]) to cytologic examination may improve the sensitivity of EUS-FNA for diagnosing pancreatic cancer, especially in patients with small primary tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/61-67\">",
"     61-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study with 394 patients with pancreatic masses, K-ras mutations were present in 266 of 307 patients (87 percent) with pancreatic ductal adenocarcinoma and in 3 of 87 patients (3 percent) with non-pancreatic ductal adenocarcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/67\">",
"     67",
"    </a>",
"    ]. When the results of the K-ras mutation analysis were combined with cytohistopathologic results, the sensitivity for detecting pancreatic ductal adenocarcinoma was 93 percent and the sensitivity was 100 percent. However, others report a lower sensitivity (38 percent) of K-ras mutations for the detection of pancreatic cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/66\">",
"     66",
"    </a>",
"    ]. At present, molecular analysis of pancreatic aspirate is not a routine component of the diagnostic evaluation for pancreatic masses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     EUS WITH CORE-NEEDLE BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of EUS-guided core-needle (trucut) biopsy in the evaluation of pancreatic masses is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"     \"Endoscopic ultrasound guided trucut biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     COST-EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several analyses of the costs related to the diagnosis and staging of pancreatic cancer have involved strategies using endoscopic ultrasound (EUS) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/38,68-71\">",
"     38,68-71",
"    </a>",
"    ]. Taken together, they suggest that EUS combined with EUS-guided fine-needle aspiration (EUS-FNA) may be a cost-effective strategy for the evaluation of patients suspected of having pancreatic cancer.",
"   </p>",
"   <p>",
"    As an example, one study included 44 patients who underwent EUS-FNA of pancreatic lesions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1929/abstract/70\">",
"     70",
"    </a>",
"    ]. The findings of EUS, in combination with EUS-FNA, precluded surgery in 12 patients (27 percent). In addition, EUS-FNA avoided the need for further diagnostic tests in 25 patients (57 percent) and influenced clinical decisions in 30 patients (68 percent). The authors estimated that the cost savings, based upon avoided surgeries, was approximately $3300 per patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CLINICAL ALGORITHM",
"    </span>",
"    &nbsp;&mdash;&nbsp;An approach to the evaluation of patients with suspected pancreatic cancer is shown in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef82523 \" href=\"UTD.htm?35/37/36432\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Staging patients with pancreatic cancer includes evaluating for tumor-node-metastasis (TNM) stage and determining if vascular invasion is present. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The goals of preoperative staging are to identify patients who might benefit from surgery and to avoid surgery in patients who have locally advanced or metastatic disease.",
"     </li>",
"     <li>",
"      A variety of studies, including endoscopic ultrasound (EUS) and computed tomography, are available for preoperative diagnosis and staging of pancreatic cancer. The imaging modalities chosen should take into account the studies' accuracy as well as local expertise. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The reported accuracy of EUS for TNM staging and for determining vascular invasion is highly variable. Given this variability, EUS is typically used as a complementary imaging modality in patients who have apparently resectable disease on computed tomography or magnetic resonance imaging. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Accuracy of EUS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Clinical algorithm'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Experience of the endosonographer may improve accuracy. We suggest that the endosonographer should have performed at least 100 EUS examinations for pancreatic tumor staging. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Accuracy of EUS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indications for EUS-guided fine-needle aspiration (EUS-FNA) in patients with pancreatic cancer are controversial. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'EUS-FNA'",
"      </a>",
"      above.) EUS-FNA can be used to:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Help plan chemotherapy or radiotherapy in patients with distant metastases who are poor surgical candidates or have advanced locoregional disease",
"     </li>",
"     <li>",
"      Rule out other types of malignancy involving the pancreas that can mimic adenocarcinoma, as well as non-malignant processes, such as autoimmune or chronic pancreatitis",
"     </li>",
"     <li>",
"      Assist with surgical planning",
"     </li>",
"     <li>",
"      Verify the diagnosis of pancreatic cancer prior to surgery for patients who desire confirmation",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/1\">",
"      Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006; 24:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/2\">",
"      Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/3\">",
"      S��ftoiu A, Vilmann P. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound 2009; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York  Vol 2010, p.241.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/5\">",
"      Varadarajulu S, Wallace MB. Applications of endoscopic ultrasonography in pancreatic cancer. Cancer Control 2004; 11:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/6\">",
"      Dewitt J, Devereaux BM, Lehman GA, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006; 4:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/7\">",
"      Snady H, Bruckner H, Siegel J, et al. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994; 40:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/8\">",
"      R&ouml;sch T, Dittler HJ, Strobel K, et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 2000; 52:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/9\">",
"      R&ouml;sch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/10\">",
"      Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999; 50:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/11\">",
"      R&ouml;sch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991; 37:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/12\">",
"      Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/13\">",
"      Grimm H, Maydeo A, Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/14\">",
"      Tio TL, Tytgat GN, Cikot RJ, et al. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990; 175:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/15\">",
"      M&uuml;ller MF, Meyenberger C, Bertschinger P, et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/16\">",
"      Yasuda K, Mukai H, Nakajima M, Kawai K. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy 1993; 25:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/17\">",
"      Ahmad NA, Lewis JD, Ginsberg GG, et al. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000; 52:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/18\">",
"      Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004; 99:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/19\">",
"      DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/20\">",
"      Puli SR, Singh S, Hagedorn CH, et al. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest Endosc 2007; 65:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/21\">",
"      Yasuda K, Mukai H, Fujimoto S, et al. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/22\">",
"      Nakaizumi A, Uehara H, Iishi H, et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig Dis Sci 1995; 40:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/23\">",
"      Brugge WR, Lee MJ, Kelsey PB, et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 1996; 43:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/24\">",
"      Hunt GC, Faigel DO. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002; 55:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/25\">",
"      Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000; 52:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/26\">",
"      Midwinter MJ, Beveridge CJ, Wilsdon JB, et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/27\">",
"      Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/28\">",
"      Tierney WM, Francis IR, Eckhauser F, et al. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc 2001; 53:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/29\">",
"      Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002; 97:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/30\">",
"      Smith SL, Rajan PS. Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol 2004; 59:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/31\">",
"      Fukushima H, Itoh S, Takada A, et al. Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma. Eur Radiol 2006; 16:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/32\">",
"      Ahmad NA, Kochman ML, Lewis JD, et al. Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma. J Clin Gastroenterol 2001; 32:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/33\">",
"      Ahmad NA, Lewis JD, Siegelman ES, et al. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 2000; 95:1926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/34\">",
"      Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999; 50:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/35\">",
"      Shami VM, Mahajan A, Loch MM, et al. Comparison between endoscopic ultrasound and magnetic resonance imaging for the staging of pancreatic cancer. Pancreas 2011; 40:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/36\">",
"      Heinrich S, Goerres GW, Sch&auml;fer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005; 242:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/37\">",
"      Schick V, Franzius C, Beyna T, et al. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging 2008; 35:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/38\">",
"      Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/39\">",
"      Williams DB, Sahai AV, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/40\">",
"      tenBerge J, Hoffman BJ, Hawes RH, et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 2002; 55:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/41\">",
"      Chang KJ, Albers CG, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol 1995; 90:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/42\">",
"      Atiq M, Bhutani MS, Ross WA, et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas 2013; 42:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/43\">",
"      El Hajj II, Leblanc JK, Sherman S, et al. Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience. Pancreas 2013; 42:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/44\">",
"      Chen J, Yang R, Lu Y, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol 2012; 138:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/45\">",
"      Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review. Pancreas 2013; 42:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/46\">",
"      Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005; 62:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/47\">",
"      Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc 2009; 70:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/48\">",
"      Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010; 71:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/49\">",
"      Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000; 51:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/50\">",
"      Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011; 106:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/51\">",
"      M&ouml;ller K, Papanikolaou IS, Toermer T, et al. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc 2009; 70:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/52\">",
"      Madhoun MF, Wani SB, Rastogi A, et al. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy 2013; 45:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/53\">",
"      Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc 2006; 63:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/54\">",
"      Qian X, Hecht JL. Pancreatic fine needle aspiration. A comparison of computed tomographic and endoscopic ultrasonographic guidance. Acta Cytol 2003; 47:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/55\">",
"      Erturk SM, Mortel&eacute; KJ, Tuncali K, et al. Fine-needle aspiration biopsy of solid pancreatic masses: comparison of CT and endoscopic sonography guidance. AJR Am J Roentgenol 2006; 187:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/56\">",
"      Mallery JS, Centeno BA, Hahn PF, et al. Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002; 56:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/57\">",
"      Volmar KE, Vollmer RT, Jowell PS, et al. Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc 2005; 61:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/58\">",
"      Fornari F, Civardi G, Cavanna L, et al. Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 1989; 24:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/59\">",
"      Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 2003; 58:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/60\">",
"      Chen VK, Arguedas MR, Kilgore ML, Eloubeidi MA. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am J Gastroenterol 2004; 99:2223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/61\">",
"      Urban T, Ricci S, Grange JD, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 1993; 85:2008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/62\">",
"      Matsubayashi H, Canto M, Sato N, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006; 66:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/63\">",
"      Teich N, Mossner J. Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors? Dig Dis 2004; 22:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/64\">",
"      Chen R, Pan S, Cooke K, et al. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 2007; 34:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/65\">",
"      Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002; 97:2263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/66\">",
"      Tr&uuml;mper L, Menges M, Daus H, et al. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial. J Clin Oncol 2002; 20:4331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/67\">",
"      Ogura T, Yamao K, Sawaki A, et al. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. Gastrointest Endosc 2012; 75:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/68\">",
"      Buscail L, Pag&egrave;s P, Berth&eacute;lemy P, et al. Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 1999; 50:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/69\">",
"      Tierney WM, Fendrick AM, Hirth RA, Scheiman JM. The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas. Am J Gastroenterol 2000; 95:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/70\">",
"      Chang KJ, Nguyen P, Erickson RA, et al. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997; 45:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1929/abstract/71\">",
"      Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma. Am J Gastroenterol 2001; 96:2651.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5638 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-0970125B04-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1929=[""].join("\n");
var outline_f1_56_1929=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Goal of staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TNM staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Evaluation of vascular invasion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ACCURACY OF EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TNM stage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vascular invasion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      COMPARISON OF EUS WITH OTHER IMAGING TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Helical CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Multidetector row CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PET scanning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EUS-FNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Accuracy of EUS-FNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      EUS-FNA versus percutaneous image-guided FNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Molecular genetic analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      EUS WITH CORE-NEEDLE BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      COST-EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CLINICAL ALGORITHM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/5638\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/5638|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?35/37/36432\" title=\"algorithm 1\">",
"      Dx pancreatic cancer algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/5638|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/11/33971\" title=\"diagnostic image 1\">",
"      T4 pancreatic cancer EUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/5638|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/32/43532\" title=\"table 1\">",
"      TNM panc endo exo CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/12/39114?source=related_link\">",
"      Chemotherapy for advanced exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41610?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=related_link\">",
"      Endoscopic ultrasound guided trucut biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/43/8884?source=related_link\">",
"      Endoscopic ultrasound: Normal pancreaticobiliary anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=related_link\">",
"      Epidemiology and risk factors for exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33370?source=related_link\">",
"      Management of locally advanced and borderline resectable exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/34/8746?source=related_link\">",
"      Surgery in the treatment of exocrine pancreatic cancer and prognosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1930="Reducing adverse obstetrical outcomes through safety sciences";
var content_f1_56_1930=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Reducing adverse obstetrical outcomes through safety sciences",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Christopher S Ennen, MD, FACOG, LCDR, MC, USN",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Andrew J Satin, MD, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/56/1930/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/56/1930/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient safety is about minimizing error and preventing harm. Reasons for errors include human fallibility, medical complexity, system deficiencies, and defensive barriers. In 1999, the Institute of Medicine estimated that medical errors account for up to 98,000 deaths each year in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although there are more than 4 million hospitalizations related to childbirth in the United States each year, there is a paucity of data specifically addressing medical errors in obstetrics. Nevertheless, medical errors do not spare this population and it is likely that strategies to reduce these errors would benefit pregnant women and their children.",
"   </p>",
"   <p>",
"    Strategies to reduce errors and subsequent adverse outcomes have focused on team and individual training; simulations and drills; development of protocols, guidelines and checklists; use of information technology; and education [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/1\">",
"     1",
"    </a>",
"    ]. These activities and tools apply to inpatient and office settings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/2\">",
"     2",
"    </a>",
"    ]. Although most studies describe positive reactions among participants and improvements in knowledge, skills, and behavior, data on patient outcomes after clinician training programs are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/3\">",
"     3",
"    </a>",
"    ]. It appears, however, that further investment in healthcare delivery and patient safety science are needed to improve patient outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/4\">",
"     4",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TEAMWORK TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failures in teamwork and communication account for 70 percent of sentinel events in obstetrics [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/5\">",
"     5",
"    </a>",
"    ]. Recognizing this, the Joint Commission, the American College of Obstetricians and Gynecologists, and the Institute of Medicine all acknowledge that",
"    <span class=\"nowrap\">",
"     teamwork/communication",
"    </span>",
"    is a critical element of patient safety [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/1,5,6\">",
"     1,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a labor and delivery setting, the patient and her baby are not cared for solely by her obstetric providers, but also by nurses, anesthesia and pediatric providers, and support staff. Formal teamwork training is increasingly becoming a part of the orientation of new hospital staff members, with the goal of improving teamwork and communication [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. There is some evidence (reviewed below) that formal training in these concepts will improve patient safety, team performance, and maternal-fetal outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Training methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of training methods and evaluation tools has been developed and studied, which makes generalization of results difficult. Two of the better-known methods are:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25498781\">",
"    <span class=\"h3\">",
"     Medteams training",
"    </span>",
"    &nbsp;&mdash;&nbsp;MedTeams training is an adaptation of a program used for training emergency department personnel and is based on aviation crew resource management principles [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/9\">",
"     9",
"    </a>",
"    ]. Crew resource management has been defined as a management system that makes optimum use of all available resources: equipment, procedures, and people, to promote safety and enhance the efficiency of flight operations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/10\">",
"     10",
"    </a>",
"    ]. The core concepts of this training program are communication, situation monitoring, mutual support, and leadership [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Communication",
"      </strong>",
"      &mdash; defined techniques for communication of relevant patient information, conflict resolution, verbalizing safety concerns, and ensuring messages are correctly understood.",
"     </li>",
"     <li>",
"      <strong>",
"       Situation monitoring",
"      </strong>",
"      &mdash; the process of scanning the labor and delivery landscape to observe and monitor patients' care plans, other team members' behaviors, or the environment.",
"     </li>",
"     <li>",
"      <strong>",
"       Mutual support",
"      </strong>",
"      &mdash; the development of the interdependence that is crucial for teams to function well.",
"     </li>",
"     <li>",
"      <strong>",
"       Leadership",
"      </strong>",
"      &mdash; designating and clarifying the roles and responsibilities of team members, reallocating resources to balance workload, ensuring that team meetings, huddles, briefings, and debriefings occur, helping team members resolve interpersonal or cognitive conflicts.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A criticism of the MedTeams approach is its reliance upon the concept of crew resource management at the exclusion of other aspects of team training science.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25498790\">",
"    <span class=\"h3\">",
"     Team STEPPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A more inclusive teamwork training program, TeamSTEPPS&reg; (Team Strategies and Tools to Enhance Performance and Patient Safety), was created to address this criticism and has been implemented at many military hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/12\">",
"     12",
"    </a>",
"    ]. The Agency for Healthcare Research and Quality is currently implementing TeamSTEPPS training nationwide (",
"    <a class=\"external\" href=\"file://teamstepps.ahrq.gov/\">",
"     file://teamstepps.ahrq.gov",
"    </a>",
"    ). A network of trainers is being created to provide national access to this course. There are no trials on the impact of TeamSTEPPS training in reducing adverse obstetrical outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Obstetrical outcomes of teamwork training studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following studies represent the available evidence illustrating the modest effects of teamwork training on pregnancy outcome:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25498797\">",
"    <span class=\"h3\">",
"     Department of Defense randomized trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Department of Defense evaluated the effect of teamwork training on adverse maternal and neonatal outcomes in 15 military and civilian hospitals with a combined total of over 53,000 deliveries annually [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/13\">",
"     13",
"    </a>",
"    ]. The intervention group consisted of 1307 labor and delivery personnel randomly assigned to MedTeams training; personnel assigned to the no training group served as controls. Outcomes were recorded before, and five months after, the teamwork training intervention.",
"   </p>",
"   <p>",
"    The composite maternal and neonatal outcome measure, the Adverse Outcome Index (AOI), was defined as the number of patients with one or more adverse outcomes divided by the total number of deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/14\">",
"     14",
"    </a>",
"    ]. Adverse maternal outcomes recorded included maternal death, uterine rupture, unplanned admission to an intensive care unit, unplanned return to the operating room, blood transfusion, and third- or fourth-degree vaginal laceration. Adverse neonatal outcomes recorded included intrapartum death of a fetus weighing at least 500 g at 24 or more weeks of gestation, death within seven days of birth of a baby with birth weight of at least 2500 g, neonatal birth trauma, unplanned admission of a term baby to the intensive care nursery, and five-minute Apgar score of less than 7 in a term baby. Additionally, teamwork was measured using 11 process measures that evaluated length of stay and delays in action where multiple care providers were involved.",
"   </p>",
"   <p>",
"    In both the intervention and control groups, outcomes of approximately 4000 deliveries before training were used for baseline comparisons and 10,000 deliveries after training (or no training) were used for the post-intervention evaluation. There were no differences in baseline characteristics or outcomes between the groups. Major findings of the trial were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There was no statistically significant difference between groups in the individual maternal and neonatal adverse outcomes or in the composite AOI.",
"     </li>",
"     <li>",
"      Of the 11 process measures evaluated, the only significant difference between groups was that the intervention group had a reduction in the time from decision to proceed with immediate cesarean delivery to the time of incision, which fell from 33 minutes to 21 minutes. The investigators attributed this finding to the formation of contingency teams (obstetric and anesthesia attending physicians, obstetric chief resident, labor nurse and surgical scrub nurse) at the hospitals that received teamwork training and concluded the reduction in decision-to-incision time of 10 minutes may have clinical significance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lead civilian hospital in the trial discussed above [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/13\">",
"     13",
"    </a>",
"    ] subsequently implemented a modified version of the original MedTeams teamwork training curriculum for all of their labor and delivery staff and then compared the AOI for the three years prior to program implementation with the AOI four years after implementation; the year that the processes were instituted was excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/15\">",
"     15",
"    </a>",
"    ]. After universal teamwork training, the AOI decreased from 5.9 to 4.6 percent, which represented 300 fewer women experiencing an adverse event. The number of high-severity malpractice claims fell from 13 to 5 cases. Actual incurred indemnity was not addressed.",
"   </p>",
"   <p>",
"    The investigators suggested that the improvement in outcomes in their study (in contrast to the findings of the original multi-center trial) may have been due to the longer length of follow-up, the creation of other protocols not related to teamwork training,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    better integration of the teamwork training into practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25498804\">",
"    <span class=\"h3\">",
"     Observational studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In another study, a large academic hospital instituted a comprehensive safety strategy including creation of standardized protocols, teamwork training, and training in the interpretation of fetal heart rate monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/16\">",
"     16",
"    </a>",
"    ]. They also used the AOI to evaluate composite outcome.",
"   </p>",
"   <p>",
"    After the intervention, the AOI decreased significantly and a provider survey reported significant improvement in the safety climate (ie, the sum of employee perceptions regarding overall safety within the workplace). However, there were no significant improvements in the individual outcomes comprising the AOI, other than a decrease in episiotomy rate (which has been falling worldwide anyway). The cesarean delivery rate increased over the study period (as it has worldwide). A limitation of this study was that there were no means to determine which of the several safety interventions performed may have led to the modest improvement in outcomes.",
"   </p>",
"   <p>",
"    In a subsequent study that evaluated a combination of Medteams and simulation training on a labor and delivery unit, a reduction in an adverse outcomes index was observed at 18 months follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Team performance evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Objectively evaluating team performance is a critical step in determining the effect of any teamwork training program. Despite modest evidence that teamwork training improves patient safety, it is gaining in popularity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/7,18-20\">",
"     7,18-20",
"    </a>",
"    ]. Further research is needed to determine whether, and what type of, training actually reduces adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/21\">",
"     21",
"    </a>",
"    ] and the combination of medical didactic training, teamwork theory, and simulation experience that will be most effective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following studies have attempted to create a useful means for objective measurement of teamwork in an obstetrical setting, but results have been conflicting. Of note, all of the studies used some sort of rating scale, but none evaluated patient outcomes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study evaluated two tools for rating teamwork in four obstetrical emergency scenarios [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/24\">",
"       24",
"      </a>",
"      ]. The first evaluation tool, the Human Factors Rating Scale (HFRS), adapted the Operating Room Management Attitudes' Questionnaire (ORMAQ) to obstetric scenarios. It consisted of a 45 item survey with questions on the themes of leadership-structure, confidence-assertion, information sharing, teamwork, and error. The second evaluation tool consisted of a single five-point rating scale, the Global Rating Scale (GRS), to judge overall team performance. Descriptions of each level of performance along the five-point scale were provided.",
"      <br/>",
"      <br/>",
"      These tools were evaluated by having teams complete four obstetrical emergency scenarios and then each team member used both evaluation tools (HFRS and GRS) to evaluate the team's performance. Nine external raters used the same evaluation tools to rate the teams. There was good inter-observer reliability among team members and among external raters; however, the correlation between the two groups was poor.",
"      <br/>",
"      <br/>",
"      The investigators concluded that the HFRS did not adequately differentiate the difficulty of the individual scenarios. The GRS better identified the more difficult scenarios, but was too simple to separate performance in the various domains of team performance.",
"     </li>",
"     <li>",
"      Another group created a teamwork evaluation tool using principles of crew resource management [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/25\">",
"       25",
"      </a>",
"      ]. The tool, called the Clinical Teamwork Scale (CTS), evaluates 15 items in the domains of communication, situational awareness, decision making, role responsibility, and patient friendliness. To validate this tool, three evaluators used the CTS to evaluate teams performing a shoulder dystocia drill, comparing their performance to recordings demonstrating good, average and excellent teamwork. The investigators concluded that the CTS demonstrated good construct validity, usability, and inter-rater reliability.",
"     </li>",
"     <li>",
"      A British group evaluated team performance in a standardized eclampsia drill before and after eclampsia management training [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/26\">",
"       26",
"      </a>",
"      ]. Although all of the teams received training in eclampsia management, only half of the teams were randomly assigned to also receive formal training in teamwork theory, either at their local hospital or at a regional simulation center. Teamwork performance was evaluated using a validated global rating scale (5-point Likert) to rate areas of knowledge, behavior and overall performance [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/27\">",
"       27",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Teamwork improved in all groups after eclampsia management training, but there was no additional benefit noted in those groups that also received teamwork training. The investigators suggested that the apparent lack of benefit of formal teamwork training may have been due to inadequate training in teamwork issues. It is also possible that simply receiving eclampsia education and rehearsing the eclampsia drill was sufficient to improve teamwork because of the relatively straightforward nature of eclampsia management.",
"      <br/>",
"      <br/>",
"      This conclusion was supported by a separate analysis of the participants' change in medical knowledge before and after training [",
"      <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/28\">",
"       28",
"      </a>",
"      ]. Medical knowledge was assessed using a 185 question, multiple-choice questionnaire, administered one to three weeks before the training and again one to three weeks afterwards. All of the teams had a 20-point increase in test scores after eclampsia education and drill training, but there was no difference between the teams with and without teamwork training.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SIMULATION AND DRILLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simulation of obstetrical procedures has become a common method of training individuals and teams to improve technical skills for treating emergency situations that occur infrequently. By simulating these situations, teams can learn and practice the required interventions in a safe environment, and thus potentially improve patient outcome when these situations actually occur on the labor unit. Simulation can also identify individual and team weaknesses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/29\">",
"     29",
"    </a>",
"    ]. Observations of many providers performing the same simulation can reveal the most common mistakes, allowing for development of appropriate and efficient curriculum for future training [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Lastly, simulation can augment the perceived reduction in clinical experience due to mandated reductions in resident work hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American College of Obstetricians and Gynecologists (ACOG) proposed a series of obstetric scenarios amenable to simulation training and the Society for Maternal-Fetal Medicine&rsquo;s simulation subcommittee developed a classification system for the characterization of evidence for simulation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/34\">",
"     34",
"    </a>",
"    ]. In general, the available data consistently show simulation training and drills improve performance by various measures, but there is less evidence for improvement in maternal or neonatal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The results of simulation drills in specific common obstetrical emergencies are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Eclampsia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclampsia simulation has offered insights into individual, team, and system errors that can be prevented [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/36\">",
"     36",
"    </a>",
"    ]. Realism can be added to the simulation of eclampsia and hemorrhage with modifications of commonly used models [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, a study performed in the United Kingdom compared team performance before and after eclampsia drill training [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/26\">",
"     26",
"    </a>",
"    ]. Teams were randomly assigned to training at their local hospital or in a regional simulation center. After training, the teams completed more of the basic tasks required in the management of eclamptic patients and these tasks were completed more quickly than prior to training. There were no differences between the teams trained locally or at a simulation center.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Shoulder dystocia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shoulder dystocia is an obstetric emergency with the potential for serious neonatal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maternal adverse outcome. It is usually unpredictable and unpreventable. Improper management of this emergency may worsen neonatal outcome, highlighting the need for adequate training of providers.",
"   </p>",
"   <p>",
"    The infrequent nature and special skills needed to manage shoulder dystocia combine to make it an obstetrical emergency ideally suited for simulation. Also, there are evidence-based recommendations for the proper selection, sequence, and technique of maneuvers used to resolve shoulder dystocia; these recommendations can be used to develop training programs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have demonstrated improvement in management and documentation of a simulated shoulder dystocia event after training of residents and attending physicians [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Both low- and high-fidelity simulation of shoulder dystocia improved performance in the simulated event [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/42\">",
"     42",
"    </a>",
"    ]. However, there are no studies evaluating post-training team performance during actual patient events.",
"   </p>",
"   <p>",
"    Neonatal outcomes after team simulation training have been evaluated. In three studies, the frequency of brachial plexus injury associated with shoulder dystocia fell by at least two-thirds after training [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. As an example, a retrospective study compared shoulder dystocia management and neonatal outcomes in the four years before versus after institution of a training program [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/43\">",
"     43",
"    </a>",
"    ]. Training consisted of didactic and practical training on risk factors, diagnosis, and proper management of shoulder dystocia. The rate of shoulder dystocia was similar during both periods (approximately 2 percent), but neonatal brachial plexus injury fell significantly from 9.3 percent to 2.3 percent. Persistent brachial plexus injuries at 6 and 12 months after birth were reduced, but not significantly, in babies born during the post-training period. A significant improvement was noted in use of appropriate management techniques (McRoberts' position, suprapubic pressure, internal rotation maneuvers, delivery of the posterior arm) and a significant decrease was also noted in inappropriate techniques (no recognized maneuvers performed, excessive traction, fundal pressure). Before training, the use of at least one correct maneuver was documented in only 49 percent of deliveries, versus 92 percent of deliveries after training. Since providers appeared to manage this emergency better after simulation training, it is hoped that a decrease in permanent brachial plexus injury will be shown over time.",
"   </p>",
"   <p>",
"    However, another study did not find a significant reduction in brachial plexus injuries after team training and use of simulators [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/46\">",
"     46",
"    </a>",
"    ]. The authors postulated that this may be because many of these injuries are not due to excessive traction by the clinician, and therefore not modifiable by clinician training. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Operative vaginal delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many residents do not feel competent in the performance of a forceps delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/47\">",
"     47",
"    </a>",
"    ]. It is likely that this accounts for at least a portion of the increasing number of cesarean deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adequate training in forceps delivery is likely going to require simulation for a number of reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/50\">",
"     50",
"    </a>",
"    ]. The number of faculty capable of teaching the use of forceps is declining; teaching the proper use of obstetric forceps in the clinical setting is difficult because they are primarily used in urgent or emergent situations, and the key maneuvers of blade placement by the learner are done in the vagina, thus the teacher is blind to whether placement is correct until it is complete.",
"   </p>",
"   <p>",
"    To overcome these obstacles, one group of investigators created a forceps simulation system using blades implanted with position sensors, allowing real-time and post-simulation evaluation of blade trajectory during placement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Based on objective assessment of blade trajectory and repeatability of insertion technique, the investigators found that senior obstetricians performed forceps placements in an \"excellent,\" \"very good,\" or \"good\" manner 92 percent of the time, compared to only 38 percent of the time for junior obstetricians. They also observed that residents' skills progressed with more training, showing less hesitation and better following of a trajectory modeled by an expert operator [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/53\">",
"     53",
"    </a>",
"    ]. Feedback systems have also been developed that demonstrate the amount of force that the operator is applying with forceps [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study evaluated the effect of operative vaginal delivery training on maternal and neonatal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/56\">",
"     56",
"    </a>",
"    ]. Training sessions with a senior staff member included lecture, video, and a \"doll and pelvis\" model. Materials were also provided for later individual study. This training emphasized techniques to minimize maternal and neonatal injury and to reduce the number of failed instrumental deliveries.",
"   </p>",
"   <p>",
"    Operative vaginal delivery rates were 11 percent before, and 14 percent after, the training period, similar to the overall rate of operative vaginal delivery in the United States. A comparison between outcomes for all operative vaginal deliveries in the four months after initiation of the training program with that of a historical control group found no statistically significant difference in the incidence of failed forceps or vacuum delivery or maternal anal sphincter injury. There was, however, a significant reduction in neonatal admissions to a special care nursery and in neonatal scalp and facial injuries. The investigators theorized that the improvement in neonatal outcome may have been largely due to better understanding of the correct technique of vacuum delivery, given that this was the more commonly used method.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198030000\">",
"    <span class=\"h2\">",
"     Postpartum hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum hemorrhage is a relatively common, potentially life-threatening obstetric emergency. Studies of simulation-based teaching of management of postpartum hemorrhage have demonstrated that this approach identifies important deficiencies in clinician knowledge and performance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/31,57\">",
"     31,57",
"    </a>",
"    ]. Common management errors were delay in transporting the bleeding patient to the operating room, unfamiliarity with prostaglandin administration to reverse uterine atony, poor cardiopulmonary resuscitation techniques, and delayed administration of blood products to reverse consumption coagulopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/31\">",
"     31",
"    </a>",
"    ]. One study reported improvement in knowledge of clinical management of postpartum hemorrhage, clinician confidence, and communication skills when assessed three months after training [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/58\">",
"     58",
"    </a>",
"    ] and another reported improved skills of birth attendants to correctly perform bimanual uterine compression [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/59\">",
"     59",
"    </a>",
"    ]. However, no studies have evaluated clinical outcomes after simulation training.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198030078\">",
"    <span class=\"h2\">",
"     Perimortem cesarean delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perimortem cesarean delivery is a key component of the management of cardiac arrest in pregnancy, and can be life-saving for the mother",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetus. Delivery of the infant within five minutes of maternal cardiac arrest is critical. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/22/20840?source=see_link&amp;anchor=H9057240#H9057240\">",
"     \"Management of cardiopulmonary arrest in pregnancy\", section on 'Delivery as part of the resuscitation process'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Managing Obstetric Emergencies and Trauma (MOET) course, which includes perimortem cesarean delivery, provides clinicians with a systematic approach to dealing with obstetrical emergencies. A retrospective study found that performance of perimortem cesarean delivery significantly increased after the course (from four procedures or",
"    <span class=\"nowrap\">",
"     0.36/year",
"    </span>",
"    to eight procedures or",
"    <span class=\"nowrap\">",
"     1.6/year),",
"    </span>",
"    although none of the cesareans was performed within the recommended five&nbsp;minutes after starting resuscitation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/60\">",
"     60",
"    </a>",
"    ]. Nevertheless, 8 of the 12 women regained cardiac output after delivery, with two maternal and five neonatal survivors.",
"   </p>",
"   <p>",
"    In another study, maternal-fetal medicine staff (attendings and fellows) demonstrated significant improvement in knowledge, confidence, and management after participating in a simulated-based curriculum for managing maternal cardiac arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/61\">",
"     61",
"    </a>",
"    ]. The educational intervention included the American Heart Association Basic Life Support training followed by a didactic session focusing on the management of cardiac arrest during pregnancy. Participants then participated in a simulation session with immediate feedback, completed a multiple choice test, and took a confidence survey. Postintervention evaluation three weeks later showed significant improvement in simulation performance, knowledge and confidence. Significant improvements occurred in timely initiation of cardiopulmonary resuscitation (median 32 versus 120 seconds) and timely initiation of cesarean delivery (median time 159 versus 240 seconds).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of simulators has been demonstrated to improve performance of amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/62\">",
"     62",
"    </a>",
"    ] and vaginal breech delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective study investigated the benefit of a structured training course on neonatal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/64\">",
"     64",
"    </a>",
"    ]. The course lasted a full day, with didactic training in electronic fetal monitoring in the morning, followed by an afternoon session of emergency drills to review the management of shoulder dystocia, postpartum hemorrhage, eclampsia, twins, breech, and adult and neonatal resuscitation.",
"   </p>",
"   <p>",
"    Review of neonatal outcomes before and after implementation of the training sessions showed a significant reduction in five-minute Apgar scores &lt;7 and hypoxic-ischemic encephalopathy. Infants born &lt;37 weeks of gestation, multiple pregnancies, infants born breech (either vaginally or by cesarean) and those born by elective cesarean were excluded, and maternal outcomes were not evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Retention of skills",
"    </span>",
"    &nbsp;&mdash;&nbsp;One concern with using simulation training is the retention of skills. If training can help reduce adverse outcomes, it is important to know how frequently it must be performed.",
"   </p>",
"   <p>",
"    This issue was addressed in a study of skill retention after simulation training for management of shoulder dystocia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/65\">",
"     65",
"    </a>",
"    ]. The training session included a 40-minute practical workshop on shoulder dystocia management. Participants, including junior and senior physicians and midwives, performed a simulated delivery with a shoulder dystocia. The simulation ended when the participant delivered the posterior arm, elected to stop, or five minutes had elapsed. They were evaluated on whether delivery was successful, the head-to-body delivery interval, performance of appropriate actions, force applied, and communication.",
"   </p>",
"   <p>",
"    Each participant did the simulation once before the training session and at three time points after training. The fetus with shoulder dystocia was successfully delivered in 49 percent of simulations before training, and in 82, 84, and 85 percent of simulations at 3 weeks, 6 months, and 12 months after training, respectively. Additional training of the 18 percent of participants who were unable to deliver the fetus 3 weeks after training resulted in a 79 percent rate of successful delivery in this group at 12 months.",
"   </p>",
"   <p>",
"    The investigators concluded that annual training is adequate for providers demonstrating competency after initial training. However, those that were unsuccessful three weeks after training should have remediation and be followed more closely to ensure retention of skills. This study also highlights the fact that providers do not all learn in the same way or at the same rate and that to achieve maximal benefit, some individualization of simulation training is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CHECKLISTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Oxytocin administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     Oxytocin",
"    </a>",
"    is a commonly used medication to stimulate labor. While many dose regimens have been evaluated, there is insufficient evidence to recommend a dosing protocol that is appropriate for all patients. The best dose regimen likely varies among patients or types of patients. It is possible, however, that more uniform practice could improve safety. Some experts recommend oxytocin protocols, which emphasize strict maternal and fetal criteria when administering the medication, the use of low initial doses with infrequent dose increases, and strong collaboration between physicians and nurses. Adherence to protocols and checklists may reduce medicolegal risk, while establishing",
"    <span class=\"nowrap\">",
"     protocols/checklists",
"    </span>",
"    and then violating them may increase that risk [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/66-69\">",
"     66-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large hospital corporation published data on the effects of implementing a checklist-based system for use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/70\">",
"     70",
"    </a>",
"    ]. They purposely created a \"conservative\" protocol with the intention that a standing order could be safely implemented by nurses of all skill levels. The pre-oxytocin checklist required adequate documentation that the patient was an appropriate candidate for labor (appropriate estimated fetal weight, fetal presentation, clinical pelvimetry, fetal assessment, etc). An \"in-use\" oxytocin checklist included fetal assessment by heart rate pattern and uterine assessment by pattern and strength of contractions (either by palpation or with an intrauterine pressure catheter); this checklist was to be completed every 30 minutes while the patient received the medication. If all of the items on the checklist could not be completed, then the oxytocin infusion was reduced or stopped. The infusion could be restarted if both the pre-oxytocin and in-use checklist were completed.",
"   </p>",
"   <p>",
"    To evaluate the effect of the checklist, the investigators compared the outcomes of 100 patients in one hospital who received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    just before implementation of the checklist-based protocol to the outcome of 100 patients who received oxytocin just after implementation of the checklist. The groups were similar at baseline and had a similar total duration of oxytocin infusion. There were no differences between groups in cesarean delivery rates or specific adverse neonatal outcomes (intensive care nursery admission, respiratory distress, sepsis suspected or confirmed). There was a clinically negligible, but statistically significant, reduction in maximum oxytocin dose from 13.8",
"    <span class=\"nowrap\">",
"     mU/min",
"    </span>",
"    to 11.4",
"    <span class=\"nowrap\">",
"     mU/min",
"    </span>",
"    and a reduction in the total number of neonates with any adverse outcome, which fell from 31 to 18 neonates.",
"    <br/>",
"    <br/>",
"    Based on the perceived success of the oxytocin checklist, the same hospital corporation instituted similar checklists for the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    , the performance of operative vaginal delivery, and the management of shoulder dystocia and abnormal fetal heart rate tracings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/71\">",
"     71",
"    </a>",
"    ]. They subsequently observed a decrease in litigation, as well as a one-year reduction in the cesarean delivery rate. No further data were provided about maternal or neonatal outcome. Ascribing all of the positive outcomes to implementation of checklists may not be warranted, as the hospital corporation employed several other initiatives during this period, such as increased physician presence in the hospitals. Their approach to patient safety now encompasses 11 principles [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PRACTICE GUIDELINES AND PROTOCOLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consistent use of well-developed, evidence-based practice guidelines results in universal application of best practices and can improve patient outcomes, as illustrated by the following examples. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/35/20024?source=see_link\">",
"     \"Clinical practice guidelines\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Late preterm elective delivery",
"    </strong>",
"    &ndash; The Ohio Perianatal Quality Collaborative, recognizing the increased rates of neonatal morbidity for infants born at &lt;39 completed weeks of gestation, sought to reduce overall morbidity by reducing elective deliveries between 36",
"    <span class=\"nowrap\">",
"     0/7",
"    </span>",
"    and 38",
"    <span class=\"nowrap\">",
"     6/7",
"    </span>",
"    weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/73\">",
"     73",
"    </a>",
"    ]. The group created a set of recommended practices, including promotion of ultrasound examination before 20 weeks of gestation to confirm dating, utilization of the American College of Obstetricians and Gynecologists criteria for scheduled birth, improving communication between obstetric and pediatric providers and promoting a culture of safety. &nbsp;These interventions resulted in a decrease in the rate of elective scheduled births from 25 percent before implementation to &lt;5 percent after.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Third and fourth degree lacerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to reduce the frequency of third- and fourth-degree lacerations associated with operative vaginal delivery, one institution instituted a training program and provided practice guidelines for this procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/74\">",
"     74",
"    </a>",
"    ]. Recommendations included using vacuum extraction instead of forceps when possible, converting occiput posterior to occiput anterior prior to delivery, and performing a mediolateral episiotomy if an episiotomy was necessary. The guidelines were promulgated via departmental conferences, distribution of reading materials, and instructional posters.",
"   </p>",
"   <p>",
"    The investigators reviewed outcomes for the nine months before the intervention began and for the first nine months afterwards. After the training and guidelines were initiated, there was a significant increase in the use of vacuum rather than forceps and a significant reduction in the frequency of third and fourth decree lacerations related to operative vaginal deliveries, from 41 percent to 26 percent. Among these patients, the incidence of fourth-degree lacerations decreased from 30 to 19 percent. There were no differences in neonatal outcomes (admission to neonatal intensive care unit, transfusion, Apgar scores, intraventricular hemorrhage, nerve injury, or laceration).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Peripartum hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study, a hospital implemented a comprehensive program to improve patient safety following the deaths of two patients from hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/75\">",
"     75",
"    </a>",
"    ]. Training sessions discussing the new guidelines, as well as the recognition and management of severe obstetric hemorrhage, were regularly performed. The program consisted of several components:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstetric rapid response teams to respond to obstetric emergencies",
"     </li>",
"     <li>",
"      Performance of quarterly drills of various emergencies",
"     </li>",
"     <li>",
"      Development of clinical guidelines and pathways",
"     </li>",
"     <li>",
"      Relieving the in-house obstetrician of caring for gynecologic emergencies and asking this physician to monitor all patients on labor and delivery, regardless of who their primary physician was.",
"     </li>",
"     <li>",
"      A policy whereby all members of the labor and delivery team were empowered to consult with a senior department member if there was a disagreement about the care of a patient. This senior physician would immediately discuss the issue with the attending physician.",
"     </li>",
"     <li>",
"      The hospital's trauma team, as experts in hemorrhagic shock, was made available to consult on all cases of severe obstetric hemorrhage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To evaluate the effect of this intervention, the investigators compared patient outcomes from the year prior to the intervention with outcomes four years after its implementation. Patient characteristics were similar between the two periods, as was the occurrence of placenta accreta and the severity of hemorrhage. Maternal deaths due to hemorrhage decreased from two to none. The small number of serious events precludes drawing conclusions regarding the effectiveness of this program. However, there was a significant improvement in nonspecific markers of effective resuscitation, such as maternal pH and temperature.",
"   </p>",
"   <p>",
"    In a second study, another hospital evaluated all of their cases of massive (defined at &gt;1000 mL) postpartum hemorrhage over a six-month period in an attempt to improve management of this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/76\">",
"     76",
"    </a>",
"    ]. Each case was examined to identify deviation from hospital guidelines. The guidelines were then revised to reduce practice deviation, the staff was trained in management of postpartum hemorrhage, and practice drills were implemented.",
"   </p>",
"   <p>",
"    Deviations from guidelines fell from 37 percent in the initial six-month period to none in the second six-month period. The incidence of massive postpartum hemorrhage fell from 1.7 percent to 0.45 percent and there were fewer blood transfusions and admissions to higher level care units.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     INFORMATION TECHNOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review including 257 studies evaluated evidence on the effect of health information technology on quality, efficiency, and cost of care [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/77\">",
"     77",
"    </a>",
"    ]. Of note, there were few studies focused on obstetrics and only four academic institutions accounted for 25 percent of these publications.",
"   </p>",
"   <p>",
"    Use of information technology was associated with three major benefits with respect to quality of care: increased adherence to guideline based care; enhanced patient surveillance and monitoring; and decreased medication errors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25499147\">",
"    <span class=\"h1\">",
"     UNIT-BASED PROGRAMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Comprehensive Unit-Based Safety Program (CUSP) is a safety culture program designed to educate and improve awareness about patient safety and quality of care, empower staff to take charge and improve safety in their unit, create partnerships between units and hospital managers to improve organizational culture and provide resources for unit improvement efforts, and provide tools to investigate and learn from defects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/78\">",
"     78",
"    </a>",
"    ]. The program uses a structured process that allows it to be integrated into the hospital&rsquo;s strategic plan, while taking advantage of local unit&rsquo;s experience. Key elements of the program include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Staff education on safety science",
"     </li>",
"     <li>",
"      Identification of potential hazards",
"     </li>",
"     <li>",
"      Partnering with a hospital executive",
"     </li>",
"     <li>",
"      Learning from previous problems. This requires answering four questions: What happened? Why did it happen? What was done to reduce risk? How do we know that the risk was actually reduced?",
"     </li>",
"     <li>",
"      Implementing tools to improve teamwork, communication, and the culture of safety",
"     </li>",
"     <li>",
"      Ongoing measurement, feedback, and improvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A pre- and post-implementation evaluation of CUSP in two surgical intensive care units at Johns Hopkins Hospital found it was associated with an improvement in safety culture and a reduction in length of stay, medication errors, and possibly nursing turnover [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/79-81\">",
"     79-81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     RESIDENT EDUCATION AND WORK HOURS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2003, the Accreditation Council for Graduate Medical Education (ACGME) established the 80-hour work week for all residency programs. Subsequently, the Institute of Medicine released a report recommending adjustments to the ACGME guidelines, including reductions in maximum shift length without time for sleep and number of consecutive night shifts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these guidelines were based on research into sleep and human performance, they were instituted without evidence that they reduce adverse events or have no adverse impact on resident education. Reassuringly, two years after initiation of reduced work hours in New York, a survey of resident and attending physicians found significant improvement in resident lifestyle without a decrease in surgical case load [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/83\">",
"     83",
"    </a>",
"    ]. There was, however, no perceived improvement in quality of care.",
"   </p>",
"   <p>",
"    In another survey, residents in training both before and after the initiation of the 80-hour work reported increased satisfaction with personal lives after the restriction of work hours, but no change in job satisfaction or CREOG scores [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/84\">",
"     84",
"    </a>",
"    ]. There was a statistically significant decrease in weekly work hours reported, from 89 to 83 hours. The residents did not report an increased amount of sleep at home.",
"   </p>",
"   <p>",
"    Educators surveyed about the impact of the reduction in resident work hours reported they felt residents' interest in teaching, time available to teach, surgical volume, and overall education had deteriorated, but resident morale had improved [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/85\">",
"     85",
"    </a>",
"    ]. They reported no perceived difference in patient safety following the enactment of reduced work hours, but also felt that reduced hours would have a positive effect on medical student recruitment into obstetrics and gynecology. One investigator reported no significant reduction in residents&rsquo; experience with core surgical procedures since the implementation of mandated limits on work hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another survey of faculty, residents and interns found that residents spent less time teaching after implementation of reduced work hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence that mandated reduction in obstetric resident work hours has reduced adverse obstetric outcomes. For example, in one study in a metropolitan hospital, the investigators compared outcomes in the year before and after the initiation of the 80-hour work week [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/88\">",
"     88",
"    </a>",
"    ]. They noted a slight decrease in maternal hemorrhage (from 2.0 to 1.2 percent) and a slight increase in the primary cesarean delivery rate (from 14.5 to 16.1 percent). Other obstetric outcomes were the same. One study reported a correlation between surgical resident work hour restrictions and improved patient outcomes on a surgical service [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/89\">",
"     89",
"    </a>",
"    ], although multiple other studies in the surgical literature failed to show a significant difference in morbidity or mortality between pre- and post-restriction periods [",
"    <a class=\"abstract\" href=\"UTD.htm?1/56/1930/abstract/90-92\">",
"     90-92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is a paucity of data specifically addressing medical errors in obstetrics. Nevertheless, medical errors do not spare this population and it is likely that strategies to reduce these errors would benefit pregnant women and their children. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Teamwork and communication failures contribute to 70 percent of sentinel events in obstetrics. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Teamwork training'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite limited evidence of improvement in patient safety, implementation of teamwork training concepts is growing and likely to remain a part of obstetric training. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Teamwork training'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Simulation training improves clinician performance in multiple obstetric simulation scenarios, but prospective studies assessing direct clinical care are lacking. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Simulation and drills'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multifaceted approaches to enhance the overall safety climate include use of clinical protocols, guidelines, and checklists. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Checklists'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Practice guidelines and protocols'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21292468\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Navy or the Department of Defense.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Kohn, LT, Corrigan, JM, Donaldson, MS, Eds; Committee on Quality of Health Care in America, Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/2\">",
"      Erickson TB, Kirkpatrick DH, DeFrancesco MS, Lawrence HC 3rd. Executive summary of the American College of Obstetricians and Gynecologists Presidential Task Force on Patient Safety in the Office Setting: reinvigorating safety in office-based gynecologic surgery. Obstet Gynecol 2010; 115:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/3\">",
"      van Lonkhuijzen L, Dijkman A, van Roosmalen J, et al. A systematic review of the effectiveness of training in emergency obstetric care in low-resource environments. BJOG 2010; 117:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/4\">",
"      Pronovost PJ, Holzmueller CG, Ennen CS, Fox HE. Overview of progress in patient safety. Am J Obstet Gynecol 2011; 204:5.",
"     </a>",
"    </li>",
"    <li>",
"     Joint Commission on Accreditation of Healthcare Organizations. JCAHO sentinel event alert #30. 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/6\">",
"      American College of Obstetricians and Gynecologists Committee Committee on Patient Safety and Quality Improvement. ACOG Committee Opinion No. 447: Patient safety in obstetrics and gynecology. Obstet Gynecol 2009; 114:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/7\">",
"      Birnbach DJ, Salas E. Can medical simulation and team training reduce errors in labor and delivery? Anesthesiol Clin 2008; 26:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/8\">",
"      Hunt EA, Shilkofski NA, Stavroudis TA, Nelson KL. Simulation: translation to improved team performance. Anesthesiol Clin 2007; 25:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/9\">",
"      Morey JC, Simon R, Jay GD, et al. Error reduction and performance improvement in the emergency department through formal teamwork training: evaluation results of the MedTeams project. Health Serv Res 2002; 37:1553.",
"     </a>",
"    </li>",
"    <li>",
"     www.raes-hfg.com/reports/crm-now.htm (accessed July 27, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/11\">",
"      Mann S, Pratt SD. Team approach to care in labor and delivery. Clin Obstet Gynecol 2008; 51:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/12\">",
"      Alonso, A, Baker, DP, Holtzman, A, et al. Reducing medical error in the Military Health System: How can team training help?. Human Resource Management Review 2006; 16:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/13\">",
"      Nielsen PE, Goldman MB, Mann S, et al. Effects of teamwork training on adverse outcomes and process of care in labor and delivery: a randomized controlled trial. Obstet Gynecol 2007; 109:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/14\">",
"      Mann S, Pratt S, Gluck P, et al. Assessing quality obstetrical care: development of standardized measures. Jt Comm J Qual Patient Saf 2006; 32:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/15\">",
"      Pratt SD, Mann S, Salisbury M, et al. John M. Eisenberg Patient Safety and Quality Awards. Impact of CRM-based training on obstetric outcomes and clinicians' patient safety attitudes. Jt Comm J Qual Patient Saf 2007; 33:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/16\">",
"      Pettker CM, Thung SF, Norwitz ER, et al. Impact of a comprehensive patient safety strategy on obstetric adverse events. Am J Obstet Gynecol 2009; 200:492.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/17\">",
"      Phipps MG, Lindquist DG, McConaughey E, et al. Outcomes from a labor and delivery team training program with simulation component. Am J Obstet Gynecol 2012; 206:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/18\">",
"      Haller G, Garnerin P, Morales MA, et al. Effect of crew resource management training in a multidisciplinary obstetrical setting. Int J Qual Health Care 2008; 20:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/19\">",
"      Nielsen P, Mann S. Team function in obstetrics to reduce errors and improve outcomes. Obstet Gynecol Clin North Am 2008; 35:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/20\">",
"      Scholefield H. Safety in obstetric critical care. Best Pract Res Clin Obstet Gynaecol 2008; 22:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/21\">",
"      Read JS, Cannon MJ, Stanberry LR, Schuval S. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008; 38:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/22\">",
"      Guise JM, Segel S. Teamwork in obstetric critical care. Best Pract Res Clin Obstet Gynaecol 2008; 22:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/23\">",
"      McConaughey E. Crew resource management in healthcare: the evolution of teamwork training and MedTeams. J Perinat Neonatal Nurs 2008; 22:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/24\">",
"      Morgan PJ, Pittini R, Regehr G, et al. Evaluating teamwork in a simulated obstetric environment. Anesthesiology 2007; 106:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/25\">",
"      Guise JM, Deering SH, Kanki BG, et al. Validation of a tool to measure and promote clinical teamwork. Simul Healthc 2008; 3:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/26\">",
"      Ellis D, Crofts JF, Hunt LP, et al. Hospital, simulation center, and teamwork training for eclampsia management: a randomized controlled trial. Obstet Gynecol 2008; 111:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/27\">",
"      Weller JM, Bloch M, Young S, et al. Evaluation of high fidelity patient simulator in assessment of performance of anaesthetists. Br J Anaesth 2003; 90:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/28\">",
"      Crofts JF, Ellis D, Draycott TJ, et al. Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation centre and teamwork training. BJOG 2007; 114:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/29\">",
"      Daniels K, Lipman S, Harney K, et al. Use of simulation based team training for obstetric crises in resident education. Simul Healthc 2008; 3:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/30\">",
"      Crofts JF, Fox R, Ellis D, et al. Observations from 450 shoulder dystocia simulations: lessons for skills training. Obstet Gynecol 2008; 112:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/31\">",
"      Maslovitz S, Barkai G, Lessing JB, et al. Recurrent obstetric management mistakes identified by simulation. Obstet Gynecol 2007; 109:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/32\">",
"      Johannsson H, Ayida G, Sadler C. Faking it? Simulation in the training of obstetricians and gynaecologists. Curr Opin Obstet Gynecol 2005; 17:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/33\">",
"      Macedonia CR, Gherman RB, Satin AJ. Simulation laboratories for training in obstetrics and gynecology. Obstet Gynecol 2003; 102:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/34\">",
"      Argani CH, Eichelberger M, Deering S, Satin AJ. The case for simulation as part of a comprehensive patient safety program. Am J Obstet Gynecol 2012; 206:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/35\">",
"      Meri&eacute;n AE, van de Ven J, Mol BW, et al. Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol 2010; 115:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/36\">",
"      Thompson S, Neal S, Clark V. Clinical risk management in obstetrics: eclampsia drills. BMJ 2004; 328:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/37\">",
"      Daniels K, Parness AJ. Development and use of mechanical devices for simulation of seizure and hemorrhage in obstetrical team training. Simul Healthc 2008; 3:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/38\">",
"      Gurewitsch ED. Optimizing shoulder dystocia management to prevent birth injury. Clin Obstet Gynecol 2007; 50:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/39\">",
"      Deering S, Poggi S, Macedonia C, et al. Improving resident competency in the management of shoulder dystocia with simulation training. Obstet Gynecol 2004; 103:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/40\">",
"      Goffman D, Heo H, Pardanani S, et al. Improving shoulder dystocia management among resident and attending physicians using simulations. Am J Obstet Gynecol 2008; 199:294.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/41\">",
"      Goffman D, Heo H, Chazotte C, et al. Using simulation training to improve shoulder dystocia documentation. Obstet Gynecol 2008; 112:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/42\">",
"      Crofts JF, Bartlett C, Ellis D, et al. Training for shoulder dystocia: a trial of simulation using low-fidelity and high-fidelity mannequins. Obstet Gynecol 2006; 108:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/43\">",
"      Draycott TJ, Crofts JF, Ash JP, et al. Improving neonatal outcome through practical shoulder dystocia training. Obstet Gynecol 2008; 112:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/44\">",
"      Inglis SR, Feier N, Chetiyaar JB, et al. Effects of shoulder dystocia training on the incidence of brachial plexus injury. Am J Obstet Gynecol 2011; 204:322.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/45\">",
"      Grobman WA, Miller D, Burke C, et al. Outcomes associated with introduction of a shoulder dystocia protocol. Am J Obstet Gynecol 2011; 205:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/46\">",
"      Walsh JM, Kandamany N, Ni Shuibhne N, et al. Neonatal brachial plexus injury: comparison of incidence and antecedents between 2 decades. Am J Obstet Gynecol 2011; 204:324.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/47\">",
"      Powell J, Gilo N, Foote M, et al. Vacuum and forceps training in residency: experience and self-reported competency. J Perinatol 2007; 27:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/48\">",
"      Maulik D. Adequate training for operative vaginal delivery. J Matern Fetal Neonatal Med 2004; 16:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/49\">",
"      Bailey PE. The disappearing art of instrumental delivery: time to reverse the trend. Int J Gynaecol Obstet 2005; 91:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/50\">",
"      Shaffer BL, Caughey AB. Forceps delivery: potential benefits and a call for continued training. J Perinatol 2007; 27:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/51\">",
"      Dupuis O, Moreau R, Silveira R, et al. A new obstetric forceps for the training of junior doctors: a comparison of the spatial dispersion of forceps blade trajectories between junior and senior obstetricians. Am J Obstet Gynecol 2006; 194:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/52\">",
"      Dupuis O, Moreau R, Pham MT, Redarce T. Assessment of forceps blade orientations during their placement using an instrumented childbirth simulator. BJOG 2009; 116:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/53\">",
"      Moreau R, Jardin A, Pham MT, et al. A new kind of training for obstetric residents: simulator training. Conf Proc IEEE Eng Med Biol Soc 2006; 1:4416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/54\">",
"      Leslie KK, Dipasquale-Lehnerz P, Smith M. Obstetric forceps training using visual feedback and the isometric strength testing unit. Obstet Gynecol 2005; 105:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/55\">",
"      Moreau R, Pham MT, Brun X, et al. Assessment of forceps use in obstetrics during a simulated childbirth. Int J Med Robot 2008; 4:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/56\">",
"      Cheong YC, Abdullahi H, Lashen H, Fairlie FM. Can formal education and training improve the outcome of instrumental delivery? Eur J Obstet Gynecol Reprod Biol 2004; 113:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/57\">",
"      Deering SH, Chinn M, Hodor J, et al. Use of a postpartum hemorrhage simulator for instruction and evaluation of residents. J Grad Med Educ 2009; 1:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/58\">",
"      Birch L, Jones N, Doyle PM, et al. Obstetric skills drills: evaluation of teaching methods. Nurse Educ Today 2007; 27:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/59\">",
"      Andreatta P, Gans-Larty F, Debpuur D, et al. Evaluation of simulation-based training on the ability of birth attendants to correctly perform bimanual compression as obstetric first aid. Int J Nurs Stud 2011; 48:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/60\">",
"      Dijkman A, Huisman CM, Smit M, et al. Cardiac arrest in pregnancy: increasing use of perimortem caesarean section due to emergency skills training? BJOG 2010; 117:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/61\">",
"      Fisher N, Eisen LA, Bayya JV, et al. Improved performance of maternal-fetal medicine staff after maternal cardiac arrest simulation-based training. Am J Obstet Gynecol 2011; 205:239.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/62\">",
"      Pittini R, Oepkes D, Macrury K, et al. Teaching invasive perinatal procedures: assessment of a high fidelity simulator-based curriculum. Ultrasound Obstet Gynecol 2002; 19:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/63\">",
"      Deering S, Brown J, Hodor J, Satin AJ. Simulation training and resident performance of singleton vaginal breech delivery. Obstet Gynecol 2006; 107:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/64\">",
"      Draycott T, Sibanda T, Owen L, et al. Does training in obstetric emergencies improve neonatal outcome? BJOG 2006; 113:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/65\">",
"      Crofts JF, Bartlett C, Ellis D, et al. Management of shoulder dystocia: skill retention 6 and 12 months after training. Obstet Gynecol 2007; 110:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/66\">",
"      Clark SL, Simpson KR, Knox GE, Garite TJ. Oxytocin: new perspectives on an old drug. Am J Obstet Gynecol 2009; 200:35.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/67\">",
"      Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol 2008; 198:622.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/68\">",
"      Miller LA. Oxytocin, excessive uterine activity, and patient safety: time for a collaborative approach. J Perinat Neonatal Nurs 2009; 23:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/69\">",
"      Simpson KR, Knox GE. Oxytocin as a high-alert medication: implications for perinatal patient safety. MCN Am J Matern Child Nurs 2009; 34:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/70\">",
"      Clark S, Belfort M, Saade G, et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol 2007; 197:480.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/71\">",
"      Clark SL, Belfort MA, Byrum SL, et al. Improved outcomes, fewer cesarean deliveries, and reduced litigation: results of a new paradigm in patient safety. Am J Obstet Gynecol 2008; 199:105.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/72\">",
"      Clark SL, Meyers JA, Frye DK, Perlin JA. Patient safety in obstetrics--the Hospital Corporation of America experience. Am J Obstet Gynecol 2011; 204:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/73\">",
"      Donovan EF, Lannon C, Bailit J, et al. A statewide initiative to reduce inappropriate scheduled births at 36(0/7)-38(6/7) weeks' gestation. Am J Obstet Gynecol 2010; 202:243.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/74\">",
"      Hirsch E, Haney EI, Gordon TE, Silver RK. Reducing high-order perineal laceration during operative vaginal delivery. Am J Obstet Gynecol 2008; 198:668.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/75\">",
"      Skupski DW, Lowenwirt IP, Weinbaum FI, et al. Improving hospital systems for the care of women with major obstetric hemorrhage. Obstet Gynecol 2006; 107:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/76\">",
"      Rizvi F, Mackey R, Barrett T, et al. Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 2004; 111:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/77\">",
"      Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006; 144:742.",
"     </a>",
"    </li>",
"    <li>",
"     Unit-Based Safety Program Improves Safety Culture, Reduces Medication Errors and Length of Stay file://www.innovations.ahrq.gov/content.aspx?id=1769 (Accessed on January 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/79\">",
"      Pronovost PJ, Berenholtz SM, Goeschel C, et al. Improving patient safety in intensive care units in Michigan. J Crit Care 2008; 23:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/80\">",
"      Pronovost P, Weast B, Rosenstein B. Implementing and validating a Comprehensive Unit-based Safety Program. J Patient Safety 2005; 1:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/81\">",
"      Timmel J, Kent PS, Holzmueller CG, et al. Impact of the Comprehensive Unit-based Safety Program (CUSP) on safety culture in a surgical inpatient unit. Jt Comm J Qual Patient Saf 2010; 36:252.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Optimizing Graduate Medical Trainee (Resident) Hours and Work Schedules to Improve Patient Safety. Resident duty hours: enhancing sleep, supervision, and safety. National Academies Press, Washington, DC 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/83\">",
"      Kelly A, Marks F, Westhoff C, Rosen M. The effect of the New York State restrictions on resident work hours. Obstet Gynecol 1991; 78:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/84\">",
"      Bailit JL, Weisberger A, Knotek J. Resident job satisfaction and quality of life before and after work hour reform. J Reprod Med 2005; 50:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/85\">",
"      Espey E, Ogburn T, Puscheck E. Impact of duty hour limitations on resident and student education in obstetrics and gynecology. J Reprod Med 2007; 52:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/86\">",
"      Smith RP. Resident technical experience in obstetrics and gynecology before and after implementation of work-hour rules. Obstet Gynecol 2010; 115:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/87\">",
"      Zahn CM, Dunlow SG, Alvero R, et al. Too little time to teach? Medical student education and the resident work-hour restriction. Mil Med 2007; 172:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/88\">",
"      Bailit JL, Blanchard MH. The effect of house staff working hours on the quality of obstetric and gynecologic care. Obstet Gynecol 2004; 103:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/89\">",
"      Privette AR, Shackford SR, Osler T, et al. Implementation of resident work hour restrictions is associated with a reduction in mortality and provider-related complications on the surgical service: a concurrent analysis of 14,610 patients. Ann Surg 2009; 250:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/90\">",
"      Hutter MM, Kellogg KC, Ferguson CM, et al. The impact of the 80-hour resident workweek on surgical residents and attending surgeons. Ann Surg 2006; 243:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/91\">",
"      de Virgilio C, Yaghoubian A, Lewis RJ, et al. The 80-hour resident workweek does not adversely affect patient outcomes or resident education. Curr Surg 2006; 63:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/56/1930/abstract/92\">",
"      Salim A, Teixeira PG, Chan L, et al. Impact of the 80-hour workweek on patient care at a level I trauma center. Arch Surg 2007; 142:708.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4463 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-A00CD60D9C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1930=[""].join("\n");
var outline_f1_56_1930=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TEAMWORK TRAINING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Training methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25498781\">",
"      - Medteams training",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25498790\">",
"      - Team STEPPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Obstetrical outcomes of teamwork training studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25498797\">",
"      - Department of Defense randomized trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25498804\">",
"      - Observational studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Team performance evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SIMULATION AND DRILLS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Eclampsia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Shoulder dystocia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Operative vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H198030000\">",
"      Postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H198030078\">",
"      Perimortem cesarean delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Retention of skills",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CHECKLISTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Oxytocin administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PRACTICE GUIDELINES AND PROTOCOLS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Third and fourth degree lacerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Peripartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      INFORMATION TECHNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25499147\">",
"      UNIT-BASED PROGRAMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      RESIDENT EDUCATION AND WORK HOURS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21292468\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/35/20024?source=related_link\">",
"      Clinical practice guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/22/20840?source=related_link\">",
"      Management of cardiopulmonary arrest in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_56_1931="Causes brain death";
var content_f1_56_1931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common causes of neurologic death in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Traumatic brain injury",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Intracranial hemorrhage",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ischemic/hypoxic insult",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Metabolic encephalopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Primary brain stem infarct",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Primary low grade CNS tumors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Treated sepsis/meningitis",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Vyas, H, Evans, J. Management of a potential organ donor. In: Recent Advances in Pediatrics. David, TJ (Ed), Royal Society of Medicine Press Ltd 2002.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1931=[""].join("\n");
var outline_f1_56_1931=null;
var title_f1_56_1932="Treatment UV HUVS";
var content_f1_56_1932=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F55294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F55294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of urticarial vasculitis/hypocomplementemic urticarial vasculitis syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Manifestations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Therapeutic agents usually effective",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pruritus",
"       </td>",
"       <td>",
"        Antihistamines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cutaneous manifestations (urticaria)",
"       </td>",
"       <td>",
"        Dapsone, corticosteroids, colchicine, hydroxychloroquine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Systemic disease",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Dapsone, corticosteroids, interferon-alfa, mycophenolate mofetil, methotrexate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Musculoskeletal",
"       </td>",
"       <td class=\"sublist_other\">",
"        NSAIDs (indomethacin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" rowspan=\"2\">",
"        Pulmonary",
"       </td>",
"       <td class=\"sublist_other\">",
"        Dapsone +/- pentoxyifylline or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        CyA +/- corticosteroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" rowspan=\"4\">",
"        Renal",
"       </td>",
"       <td class=\"sublist_other\">",
"        Corticosteroids + azathioprine or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        CyA + corticosteroids or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        Corticosteroids + hydroxychloroquine or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        Plasma exchange",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Refractory or severe systemic disease",
"       </td>",
"       <td>",
"        Dapsone + corticosteroids + cyclophosphamide or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dexamethasome pulse therapy + cyclophosphamide or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corticosteroids + low-dose gold or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon-alfa + ribavirin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1932=[""].join("\n");
var outline_f1_56_1932=null;
var title_f1_56_1933="Antigenic alterations in EB skin";
var content_f1_56_1933=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antigenic alterations in epidermolysis bullosa skin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antigen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Abnormal staining in:",
"       </td>",
"       <td class=\"subtitle1\">",
"        Usual pattern of staining",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keratin 14",
"       </td>",
"       <td>",
"        EBS-AR",
"       </td>",
"       <td>",
"        Absent or markedly reduced",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Laminin-332 (laminin-5)",
"       </td>",
"       <td>",
"        JEB-H",
"       </td>",
"       <td>",
"        Absent or markedly reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JEB-nH, generalized*",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Type XVII collagen",
"       </td>",
"       <td>",
"        JEB-nH, generalized",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JEB-nH, localized",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Type VII collagen",
"       </td>",
"       <td>",
"        RDEB, severe generalized",
"       </td>",
"       <td>",
"        Absent or markedly reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        RDEB, generalized other",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        RDEB, inversa",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        DEB-BDN (only during period of active blistering)",
"       </td>",
"       <td>",
"        Granular staining within basal and suprabasal keratinocytes; absent or markedly reduced staining along DEJ",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Plectin",
"       </td>",
"       <td>",
"        EBS-MD",
"       </td>",
"       <td>",
"        Absent or reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS-PA",
"       </td>",
"       <td>",
"        Absent or reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS-Ogna",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        &alpha;6&beta;4 Integrin",
"       </td>",
"       <td>",
"        JEB-PA",
"       </td>",
"       <td>",
"        Absent or reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS-PA",
"       </td>",
"       <td>",
"        Absent or reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JEB-nH",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Kindlin-1",
"       </td>",
"       <td>",
"        Kindler syndrome",
"       </td>",
"       <td>",
"        Absent, reduced, or normal",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BDN: bullous dermolysis of the newborn; DEB: dystrophic EB; DEJ: dermoepidermal junction; DM: Dowling-Meara; EBS: EB simplex; H: Herlitz; JEB: junctional EB; MD: muscular dystrophy; nH: non-Herlitz; PA: pyloric atresia; RDEB: recessive DEB.",
"     <br>",
"      * In the majority of JEB-nH patients.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       In a minority of patients with generalized JEB-nH (previously referred to as generalized atrophic benign EB); these patients lack concurrent abnormal staining by antibodies to laminin-332.",
"       <br>",
"        &Delta; Reported in one patient.",
"        <br>",
"         <span class=\"lozenge\">",
"          &loz;",
"         </span>",
"         Loss-of-function mutations in both KIND1 alleles may be associated with normal immunostaining.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     From: Fine JD, Eady RAJ, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58:931. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1933=[""].join("\n");
var outline_f1_56_1933=null;
var title_f1_56_1934="Contents: Endocrinology and Diabetes";
var content_f1_56_1934=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      Endocrinology and Diabetes",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Endocrinology and Diabetes",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     You receive the entire UpToDate library of specialties with your ",
"							subscription. Click on a section below to view a detailed list of topics associated ",
"							with that particular section. If you'd like to see the table of contents for other ",
"							specialties,",
"     <a href=\"UTD.htm?3/3/3134\">",
"      click here",
"     </a>",
"     .",
"     <br/>",
"     <br/>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?21/19/21823\">",
"         Adrenal disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?39/23/40318\">",
"         Calcium phosphate magnesium",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?37/50/38689\">",
"         Diabetes mellitus",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?20/54/21359\">",
"         Disorders of bone",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?8/61/9183\">",
"         Endocrine tumors",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?34/21/35165\">",
"         Endocrinology calculators",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?11/16/11521\">",
"         Fluid and electrolytes",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?25/16/25870\">",
"         Hormone physiology",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?8/15/8432\">",
"         Hypertension",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?27/28/28110\">",
"         Interactive diabetes cases",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?25/44/26318\">",
"         Lipid disorders",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?41/48/42765\">",
"         Obesity",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?31/62/32750\">",
"         Pituitary disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?12/32/12801\">",
"         Reproductive endocrine female",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?30/53/31582\">",
"         Reproductive endocrine male",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?13/36/13888\">",
"         Thyroid disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?2/57/2961\">",
"         What's new in endocrinology and diabetes mellitus",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        &nbsp;",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        <a class=\"tocItem\" href=\"UTD.htm?18/22/18798\">",
"         Patient Information",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-FA3F3445A8-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_56_1934=[""].join("\n");
var outline_f1_56_1934=null;
var title_f1_56_1935="Reduction in invasive pneumococcal disease in older adults";
var content_f1_56_1935=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Reduction in invasive pneumococcal disease in older adults after the introduction of the conjugated pneumococcal vaccine in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 370px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Pneumococcal conjugate vaccine (protects against 7 pneumococcal types; in use since 2000).",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32 by permission of Oxford University Press. Copyright &copy; 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_56_1935=[""].join("\n");
var outline_f1_56_1935=null;
